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Abstract 
The vital biological functions of hyaluronic acid in vivo has resulted in extensive 
investigation into its biomedical application. This thesis reports the biomedical 
applications of a range of innovative hyaluronic acid-based hydrogels, from 
material design and creation optimisation to relevant application. A 
comprehensive review of recent and ongoing research concerning hyaluronic 
acid-based hydrogels and their deployment within biomaterial research is 
presented. The research conducted features four subjects;  (1) the synthesis, 
characterisation, and application of a redox-responsive hyaluronic acid-based 
hydrogel for chronic wound management, (2) hydrogen phosphate-mediated 
acellular biomineralisation within a dual crosslinked hyaluronic acid hydrogel,. (3) 
the facile and additive-free synthesis of a cell-friendly Iron(III)-Glutathione 
Complex that  enhanced L929 cell growth after 7 days and reduced matrix 
metalloproteinase-13 activity, demonstrating promising application in 
osteoarthritis treatment, (4) An injectable, self-healing and MMP-inhibiting 
hyaluronic acid gel formed via crosslinking with the aforementioned iron-
glutathione complex. The original materials reported provide the basis for the 
development of numerous HA-based hydrogels that have potential significance 
in a range of biomedical fields including the assessment of glutathione levels in 
chronic wounds and cancer tissue, scaffolds for tissue regeneration, and therapy 
for osteoarthritis treatment.  
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Chapter 1   
Review on recent study of hydrogels for biomaterials 
1.1 Introduction to hydrogels  
1.1.1 Polymer-based hydrogels  
Hydrogels may be described as constant water-swollen three-dimensional 
networks formed from the crosslinking of (macro)molecules. They were first 
synthesised as “hydrophilic gels” based on glycolmethacrylate in 1960. Co-
polymers of glycolmonomothacrylate with several tenths of glycoldimethacrylate 
were found to be the most suitable material in their work for permanent contact 
with living tissues as the adjustable mechanical properties, water content and 
transparency.(1) The crosslinks may be formed by physical or chemical 
interactions between hydrophilic polymers to form a structure that displays 
properties characteristic of both solids and liquids.(1-2) Like solids, hydrogels 
deform with stress and are able to recover their initial shape within a certain stress 
range. Like liquids, hydrogels can support fluid convection and diffusion of solutes 
that are smaller than the mesh size of the network. For example, hyaluronic acid 
(HA) hydrogels (Figure 1.1) that contained over 95 wt.% water formed a stable 
structure, which will be discussed later. Commonly, hydrogels are prepared using 
hydrophilic polymers that form a crosslinked network. The significant absorption 
of a large amount of water enables the hydrogel formed to maintain its shape and 
mechanical properties, enabling hydrogels to be employed within a wide range of 
applications including biomedicine,(3–7) cleaning materials(8-11) and 
antimicrobial materials(12) in living environments, and water restoration materials 
in agriculture.(13-14) There are two categories of hydrogels based on the 
crosslinking methods; chemical and physical hydrogels. 
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Figure 1.1 Example of a cystamine crosslinked HA hydrogel, presented after 
rhodamine staining. 
1.1.1.1 Chemical hydrogels  
Chemical hydrogels contain polymer chains that are connected through simple 
covalent crosslinking that allows hydrogels to hold a particular shape.(15-16) 
There are three kinds of basic reactions to construct the scaffolds used to form 
chemical hydrogels, polymerisation, polymer crosslinking and the modification of 
macromolecules by conducting polymerisations  from pendant functional groups 
to yield graft copolymers.  
1.1.1.1.1 Polymerisation  
Chemical hydrogels may be produced from polymers created from unsaturated 
monomers by free radical homopolymerisation or copolymerisation. Examples of 
monomers that have been used to create chemical hydrogels include but not 
limited to 2-hydroxyethyl methacrylate (HEMA)(17-18), acrylamide (AM)(17), 
methacrylic acid (MAA)(18). An example of a relevant polymerisation is provided 
in Figure 1.2. The hydrogel properties can be adjusted easily through changing 
monomer ratios, for instance increasing the amount of AM relative to HEMA 
enables the formation of a material with higher swelling ratio and better 
stretchability.(17)  Not limited to this, changing the initiator, or including chelation 
agents and/or chain transfer agents during the polymerisation may be conducted 
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to control the polymerisation kinetics, and alter the properties of the subsequent 
hydrogel, which provides potential for material design and is worth further study.  
 
Figure 1.2 Schematic of homopolymerisation (top) and copolymerisation (below). 
(17) 
1.1.1.1.2 Polymer crosslinking  
Chemical hydrogels have been synthesised from crosslinked macromolecules, 
including natural-based (chitosan CS,(19-20) alginate,(20) hyaluronic acid,(21) 
gelatin(22) ) and synthetic macromolecules, for example, poly(ethylene glycol) 
(PEG) (23). To form chemical hydrogels, the polymers must possess activating 
groups that can undergo crosslinking to yield a stable network (Figure 1.3). Often 
reported as being appropriate biomaterials, the active groups (such as 
carboxylate groups, amine groups, and thiol groups) in these polymers can be 
functionalised with bioactive substances such as albumin,(24) neurotrophic 
factors(25) and aptamer (single-stranded oligonucleotides selected from 
synthetic RNA/DNA libraries)(26) that render them suitable for implant materials 
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that can induce Schwann cell proliferation and migration, and peripheral nerve 
regeneration, controllably release angiogenic growth factors .(24-26) 
 
Figure 1.3 Polymer crosslinking progress. Hydrogel formation through 
crosslinkers (a) and polymer self-crosslinking at native binding positions (b). 
1.1.1.1.3 Polymerisation  from modified macromolecules 
A  synthetic strategy is to use unsaturated bonds on the side or main chain of the 
macromolecule matrix in polymerisation. These modified macromolecules can be 
polymerised through covalent bonds with controllable hydrogel elasticity, water 
absorption, pH response, degradability and thermal sensitivity.(27-28) For 
example, acrylamide (AA) was modified onto starch melt molecule chain via 
extrusion method and  obtained starch-AA copolymer gel with a significant 
enhancement in storage modulus after polymerisation under the initiation of 
ammonium sulfate in nitrogen environment.(29) Zhang et al. reported a novel 
zwitterionic hydrogel through adding a mixture of vinylsulfonic acid (VSA, as the 
negatively charged monomer) and [2-(methacryloyloxy)ethyl]trimethylammonium 
chloride (METMAC, as the positively charged monomer) onto the surface of 
polyethersulfone membrane. VSA and METMAC were crosslinked by N,N’-
methylenebisacrylamide under UV irradiation to obtain the polyampholyte 
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hydrogel surface.(30) This zwitterionic hydrogel presented interesting anti-fouling 
properties in bovine serum albumin, humic acid, and sodium alginate models 
under static adsorption. 
1.1.1.2 Physical hydrogels  
Physical hydrogels are created by non-covalent interactions between polymer 
chains. Such interactions include ionic interactions, hydrogen bonds and 
hydrophobic interactions, and provide a way to obtain stable hydrogels without 
any potentially toxic additions, or post-polymerisation modification to form 
covalent crosslinks.(31-35)  
1.1.1.2.1 Ionic interactions  
Physical hydrogels may be formed by electrostatic interactions between opposite 
charges, such as strong ionic coordination bonds between Fe3+ and COO− groups 
present on a polymer. Such interactions enhanced the mechanical properties of 
polyacrylamide/cellulose nanofibers (CNF, contain COO- groups) composite 
hydrogels that were obtained through dual crosslinking that included Fe3+ and 
COO− physical coordination and hydrogen bonds between polyacrylamide and 
cellulose   with excellent strength and stretchability (Figure 1.4) in 2018.(31)  
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Figure 1.4 A visual image of CNF2.0-Fe3+1.5 hydrogel (2 wt.% of CNF refers to 
the polyacrylamide content and immersed in Fe3+ solution with a 
concentration of 1.5 M) exhibiting excellent strength and stretchability.(31)  
Yuan et al. obtained chitosan-based hydrogels based on negatively charged 
poly(acrylic acid) (PAAc) and positively charged 2-hydroxypropyltrimethyl 
ammonium chloride chitosan (HACC) in the presence of NaCl (Figure 1.5). Due 
to ionic interactions, the hydrogel (PAAc/HACC) presented a high tensile fracture 
stress (3.31 MPa) and Young’s modulus (2.53 MPa),(32)  
 
Figure 1.5 Schematic representation of the preparation method and network 
structure of the PAAc/HACC hydrogel.(32) 
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1.1.1.2.2 Hydrogen bond interactions 
In polymer-aqueous solutions, intra- or inter-molecular hydrogen bonds between 
polymer chains can provide physical binding sites for  polymer crosslinking. 
Acceptor atoms possess pronounced electronegativity and form hydrogen bonds 
with hydrogen atoms on adjacent polymer chains. For example, macromolecules 
that contain an ether bond (C-O-C) and hydroxyl groups (-OH) may form 
crosslinks with other water-soluble polymers that possess carboxyl (-COOH) and 
hydroxyl (-OH) groups due to the hydrogen bonds formed between oxygen and 
hydrogen. 
A facile ion-exchange reaction was reported to fabricate poly(ionic liquid) (poly(1-
vinyl-3-propionate imidazole phenothiazine sulfonic acid, abbreviated as 
poly(VPI+PTZ-(CH2)3SO3−). It was then successfully introduced in hydrogel 
preparation with chitosan molecules through hydrogen bonds interaction between 
carboxyl groups in  poly(VPI+PTZ-(CH2)3SO3−) and protonated amino groups in 
chitosan.(33) The gelation time was within 5 minutes and a material for 
maintaining and stabilising enzyme activity was obtained after electrochemical 
testing. 
Ye et al. reported several novel self-healing, pH-sensitive, and biodegradable 
hydrogels based on cytosine and guanosine-modified HA via hydrogen bond 
formation between guanosine and cytosine (Figure 1.6) in 2017.(34) A high 
strength (up to 3.71 MPa) hydrogel containing poly(vinyl alcohol) (PVA) and 
hydroxyapatite, formed through inter- and intra-molecular hydrogen bonds 
(hydroxyl groups of PVA and hydroxyl groups on hydroxyapatite) and annealing 
treatment was prepared by Chen et al. This material displayed low friction with a 
friction coefficient from 0.06-0.18 under 10-20 N load, which provided potential 
application in soft tissue and cartilage replacement.(35)  
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Figure 1.6 Illustration of hydrogen bond interactions between polymer-guanosine 
and polymer-cytosine.(34) 
1.1.1.2.3 Hydrophobic Interactions  
Hydrophobic monomers can be modified by surfactant molecules through 
chemical binding. During the polymerisation of hydrophilic monomers, surfactant-
modified hydrophobic monomers can aid micelle formation, even at low 
concentrations in the reaction system when copolymerised with a hydrophilic 
majority. The micelles then twine with the hydrophilic polymer chains and form 
into hydrogel. In 2018, Owusu-Nkwantabisah prepared a thermal stiffening 
hydrogel through hydrophobic association based on a copolymer of benzyl 
methacrylate (diluent), stearyl methacrylate (hydrophobic), and methacrylic acid 
(hydrophilic), and obtained a 100-fold increase in modulus with an increase of 25 
°C in temperature. The thermal stiffening mechanism of this hydrogel was 
proposed as the polymer chain conformational changes with increasing 
temperature  facilitated the inter-chain associations.(36) By incorporating 
hydrophobic interactions, Deng et al. presented a new method to fabricate a 
mechanically-reinforced hydrogel based on PEG of various molecular weights 
that was present in the ring-opening polymerisation of ε-caprolactone. The 
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resulting hydrogels possessed self-healable and conductive properties upon 
inclusion of Fe3+.(37) Very recent research has reported a dual-crosslinked self-
healing hydrogel system formed by polyacrylamide/lauryl methacrylate 
hydrophobic interactions as the first network and Fe3+/poly(acrylic acid) ion 
association structure as the second network.(38) The dual-network design 
provided this physical crosslinked hydrogel adjustable mechanical properties in 
tension, compression, bending and torsion with retained self-healing 
property.(38)  
1.1.2 Functional Hydrogels  
Stimuli-responsive hydrogels may undergo volume changes, gel-sol transitions, 
and changes in mechanical behaviour in response to the presence of 
environmental stimuli. These “smart” hydrogels with controllable/reversible 
properties can be applied as drug delivery systems, artificial tissue scaffolds, 
biosensing  devices and for cell manipulation.(39) In recent years, reversible 
covalent bonds have been reported to promote hydrogel assembly/disassembly 
based on cycloadditions(40-41), electrostatic interactions(42-43), redox 
reactions(44-46), and acylhydrazone bond formation/cleavage(47-48). These 
dynamic bonds allow the hydrogel to turn into a weaker, or stronger, network 
structure in the presence of the target stimulus. 
1.1.2.1 pH-Sensitive Hydrogels  
For biomaterials, hydrogels are expected to be applied in a highly complex 
environment in vivo. Many diseases may cause a local environmental pH change, 
including within a cell’s inner microenvironment. Gao et al. realised pH-
controllable drug release from xylan-based hydrogels to significantly different 
extents dependent on environmental pH which were simulated to between pH 1.5 
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and pH 7.4. Accumulative drug release (%) was observed to be 26% and 90%, 
respectively, after 8 hours continuous release.(49) A 19–40% reduction in 
chitosan-based hydrogels’ volume occurred when maintained in solution of pH 3 
compared to when maintained in solution of pH 9, as reported by Zhu et al. The 
amino groups (pKa 6.5) of chitosan are protonated at low solution pH, and so 
their interaction with water molecules increases when the hydrogel is stored in 
low pH solution.(50) Not limited to physical change, this kind of pH-responsive 
behaviour can be further optimised through combining two different pH-sensitive 
polymers, such as N,O-carboxymethyl chitosan and alginate, to realise pH-
sensitive swelling ratios via adjusting the component ratio and to be used as a 
controllable drug delivery system.(51)  
Environmental pH may also be used to stabilise hydrogels’ physical appearance 
and can be exploited to optimise their size, shape, mechanical properties and 
degradability as a final step in material processing. For example, creating 3D 
printing hydrogel materials to smaller volumes, which was  successfully 
demonstrated in a system of hyaluronic acid combined with either alginate, 
gelatin or chitosan in solutions of pH =1 or pH=4.7.(52) However, the generation 
of a highly sensitive hydrogels that can respond to small changes in solution pH 
remains a key biomedical challenge, since only a very weak solution pH change 
may be brought by abnormalities in pathology. 
1.1.2.2 Temperature-Sensitive Hydrogels  
Temperature-sensitive hydrogels can form upon a heat-induced reversible sol-to-
gel transition. For biomedical applications, the transition temperature is usually 
low to normal body temperature, from 33 °C (skin) to normal physiological 
temperature 37.5 °C.(53) High sensitivity is required since the presence of 
disease may result in a slight increase or decrease in body temperature, even in 
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thermal therapy, as the body becomes damaged at temperatures above 44 
°C.(54)  
Chen et al. disclosed a hydrogel that underwent temperature-driven sol-to-gel 
transition at mild temperatures (from 27.8 to 30.3 °C, depending on the 
components) composed of chitosan, HA and Poly(N-isopropylacrylamide).(55) In 
2015, Montero-Rama et al. prepared hydrogels via the copolymerisation of 2-(2-
methoxyethoxy)ethyl methacrylate (MEO2MA) and 2-(acetylthio)ethyl 
methacrylate (AcSEMA) and N,N,N’’,N’’-tetramethylethylenediamine (TEMED), 
using ammonium persulfate (APS) as the initiator, and observed a decreased 
equilibrium swelling that correlated with an enhanced temperature (an 
approximate range from 0 °C to 35 °C at pH 7, depending on the monomer ratio) 
at neutral condition were reported.(56) This phenomenon was  attributed to the 
introduction of hydrophobic monomer (AcSEMA), which brought a new 
hydrophobic/hydrophilic balance and also changed the hydrogel cloud point as a 
function of temperature.  
1.1.2.3 Light-Sensitive Hydrogels  
Light is an attractive stimulus to manipulate hydrogel properties due to its facile, 
and controllable, operation.(57-58) Photo-switchers that are reversible under a 
certain wavelength of light change from trans to cis, or vice versa, and have been 
applied in hydrogels. For example, azobenzene is known as a common photo-
switcher, whose configuration can be changed through light irradiation under 
different wavelength; it has a trans configuration under visible light and cis 
configuration under UV light. Based on this isomerisation, azobenzene was 
grafted onto hyaluronic acid chains, combining with host-guest supramolecular 
chemistry as presented in Figure 1.7, to yield a photo-reversible HA hydrogel. 
The storage modulus of this hydrogel can be altered reversibly from 
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approximately 950 Pa (420 nm) to 650 Pa (365 nm) upon azobenzene 
configuration change.(57)  
 
Figure 1.7 Graphic illustration of photo-reversible HA hydrogel based on 
azobenzene and β-cyclodextrin supramolecular interaction.(57) 
1.1.2.4 Self-healing hydrogels  
Self-healing hydrogels are a new class of hydrogels that are able to intrinsically 
and automatically heal physical damage without external stimuli. This fascinating 
capability promoted their value as biomaterials to mimic the automatic repairing 
and healing process after damage in living creatures, thus, restoring certain 
destroyed functions. Deng et al. prepared reversible self-healing hydrogels 
through acylhydrazone and disulfide bonds (as shown in Figure 1.8).(59) 
Acylhydrazone promotes self-healing in acidic or neutral conditions and disulfide 
bonds promote self-healing under basic conditions. However, catalytic aniline 
was needed to accelerate the acylhydrazone exchange reaction to achieve self-
healing at neutral conditions, which may limit its further bio-application. Wang et 
al. prepared a self-healing, dual-responsive hydrogel based on alginate by Schiff 
base reaction with PEG. The results of strain sweep measurements after three 
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cycles illustrated the 100% and repeatable self-healing functionality of the 
material. In addition, a 12-hour self-healing time was recorded by putting two 
individual halves of hydrogel together and observing hydrogel repair.(60) 
 
Figure 1.8 Environmental adaptive self-healing of dynamic hydrogel.(59)  
1.1.2.5 Injectable hydrogels  
Injectable hydrogels are suitable biomaterials, especially for tissue engineering 
scaffolds (61), and the healing of chronic wounds (62–64). The injectable property 
enables material administration and rapid hydrogel formation in situ, which has 
promising application in clinical medicine. Liu et al. reviewed the development of 
different biomaterials and the different approaches to creating injectable 
hydrogels for cartilage and bone tissue engineering (Figure 1.9).(65) 
Hyperbranched multi-acrylate PEG macromer (HP-PEGs) was reported that can 
form a novel injectable hydrogel in situ by thiol-ene click reaction for a stem cells 
delivery and retention platform.(66) Gel formation occurred in 96 s (2.5% w/v, HP-
PEGs) and 57 s (10% w/v, HP-PEGs) in vivo  with accelerated wound healing in 
rat models.  
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Figure 1.9 Schematic illustration of injectable hydrogel formation for cartilage- 
and bone tissue-engineering applications.(65) 
1.1.3 Development of Hydrogels as Biomaterials  
1.1.3.1 Hydrogels as Biosensors  
Hydrogels can be applied as immobilising scaffolds to act as a detection/therapy 
template.(67-69) In 2013, Khimji et al. concluded the recent development of visual 
biosensors for DNA immobilisation based on polyacrylamide hydrogels which 
possess an obvious gel-sol transition at a mild temperature.(67) DNA can be 
included within the hydrogel through copolymerisation,  as a crosslinker or 
physical mixing. Changes in the  DNA sequence can enable the hydrogels to 
detect various target analytes including Hg2+ and viruses due to the selectivity of 
specific DNA binding. Particles, for instance monolayer-polystyrene particles 
(diameter ~600 nm), can  be inserted into urease-modified 2D colloidal crystal 
hydrogels to obtain a label-free urease coupled biosensor for the analysis of urea 
and urease inhibitor.(69) An increasing urea concentration from 0-120 mM can 
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be observed by the naked eye with colour change from red to blue-purple. 
Decreased particle spacing was observed and explained as a consequence of 
urease-urea catalytic reaction, which produced NH4+ and HCO3-, and resulted in 
the hydrogel volume shrinkage.  
Another popular application is developing hydrogels as bioelectronic devices. 
(70-71) In recent research, a new type of soft ionic-type asymmetric ionic sensing 
hydrogel (AISH) tactile sensors based on PAAc/Ag0 hydrogels was developed by 
Liu and Zhang’s groups.(71) A low external working voltage (20 mV) with 
ultrahigh sensitivity (171.4 kPa−1 at 75–1500 Pa and 57.5 kPa−1 at <75 Pa) and 
ultralow detection force (0.075 Pa) were reported, enabling ultra-sensitivity for 
bio-microenvironments such as vibration of the vocal cord, and use as wearable 
bioelectronic devices.(71)  
1.1.3.2 Hydrogels for drug delivery  
The 3D network structure of hydrogels can withhold small molecular drugs, as 
demonstrated by chitosan(72) and carrageenan(73) hydrogels, and 
biomacromolecules themselves can be made into therapeutic nanohydrogels to 
be delivered, such as collagen and hyaluronic acid, which are known as “anti-
aging agents”(74).  
Karimi et al. obtained a pH- and thermo-responsive hydrogel based on the 
synthesis of tris(2-(2-formylphenoxy)ethyl)amine as a novel crosslinker, and 
realised the controllable release of metronidazole in 2018.(75) Salicylaldehyde 
was chosen to modify tris(2-chloroethyl)amine, the aldehyde groups remained 
and then reacted with the amine groups on the chitosan backbone through Schiff-
base reaction to build the hydrogel networks without the addition of reducing 
agents. This material allowed rapid release of metronidazole to acidic solution 
(pH=4), since a low pH causes the -NH2 groups to become protonated, 
- 16 - 
accompanied with increased hydrogel swelling ratio. While in basic conditions, a 
lower release rate was observed  since both protonated and deprotonated  -NH2 
groups are present and the repulsion forces decreased. Drugs can also be 
encapsulated into hydrogel beads and be released following hydrogel bead 
degradation or hydrolysis. Spherical alginate micro-hydrogel beads were 
reported to form via Ca2+/alginate coordination with encapsulated ibuprofen.(76) 
Four times higher swelling ratio of hydrogel beads was presented in phosphate 
buffered saline PBS (pH 7.4), compared with H2O (pH 6.5-7.0) and simulated 
gastric acid (pH 1.2), demonstrating responsive ibuprofen release in PBS. 
Ibuprofen release occurred because the -COOH of alginate hydrogel beads 
became ionised to COO- and Ca2+ began to exchange with Na+ in PBS, resulting 
in the alginate hydrogel beads disassemble.(76) 
1.1.3.3 Hydrogels for tissue engineering  
1.1.3.3.1 Tissue replacement  
Hydrogels maintain their shape in water for prolonged periods, which enables 
their potential use as scaffolds for tissue engineering. However, high strength and 
adjustable degradability are  often required for such materials. A double-network 
(DN) structure in which polymers were crosslinked by two different 
crosslinking/binding sites was developed that can meet multiple mechanical 
requirements of scaffold materials.(77) It has been a general method of obtaining 
very strong hydrogels by including various hydrophilic polymers, such as 
collagen, agarose, PHEMA as the first network, and poly(N,N’-dimethyl 
acrylamide) (PDMAAm) as the second network. The strength of hydrogels can 
be easily adjusted via changing the polymer matrixes and polymer ratios to make 
the scaffolds stiff or brittle.  
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Another challenge is mimicking the microstructures of native tissues to improve 
the biocompatibility of scaffolds, for example, muscles that have fibrillar structures  
due to the existence of fibre-like collagen. Combined with electrospinning 
technology, Ding et al. reported a photo-click PEG fibrous hydrogel as presented 
in Figure 1.10 and studied  human pulmonary artery smooth muscle cells 
attachment to the material.(78) Compared with the flat photo-click PEG hydrogel 
(non-fibre like), significantly deeper muscle cell penetration was found in fibre 
hydrogels (~18 µm) versus the flat hydrogels (~7 µm) within 1 day. Although 
limited infiltration depth could be reached, this study proved that creating a 
material with a biomimetic microenvironment can facilitate material 
biocompatibility.  
 
Figure 1.10 Schematic illustration of a fibrous hydrogel platform with tuneable 
stiffness, structure, and composition by integration of thiol-ene photo-click 
crosslinking chemistry, electrospinning, and combinatory protein array 
technology.(78) 
Besides the mechanical strength and biocompatibility, more details should be 
considered when hydrogels are designed for particular tissue replacement, such 
as the moisture effect when hydrogels are applied for skin material,(79) and the 
influence of friction when hydrogels are used for artificial joint prosthesis,(80).  
1.1.3.3.2 Tissue regeneration  
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Tissue regeneration requires hydrogels that not only have appropriate 
mechanical strength and biocompatibility, but also can promote cell 
proliferation/differentiation to help native tissue growth with appropriate gene 
expression. Natural biomacromolecules that are non-toxic and contain bioactive 
binding sites for cell attachment, including HA, collagen, and alginate, are ideally 
suited for this role.(81-83)  
In collagen/alginate/fibrin tri-component hydrogels, it was reported that the 
stability and mechanical properties of the hydrogels could be increased by 
increasing the collagen content.(82)  Significant proliferation of human-TERT 
mesenchymal stem cells (Y201 hMSCs) was found on the 0.5% and 1.0% w/v 
collagen tri-component hydrogels after 3 days culture. No significant cell 
proliferation occurred on the 2.5% w/v collagen hydrogel, whereas a significant 
increase of alkaline phosphate activity (ALP) of Y201 cells was detected in these 
hydrogels after 3 days culture. This interesting discovery of inhibited cellular 
proliferation with increased ALP activity implied osteoblastic differentiation and 
suggested  osteogenic potential for bone regeneration.  
Further research on using hydrogels for regenerative medicine that involved 
studying drug encapsulation and release has been performed. Yang et al. 
conjugated icarrin, a flavonoid constituent, onto HA and formed composite 
hydrogels with collagen to facilitate the reconstruction of the osteochondral 
interface.(83) Continuous and steady release of icarrin was recorded with 40% 
cumulative release within 144 hours, promising a biosafe and sustainable method 
for therapeutic delivery. The efficacy in osteochondral repair was proved through 
histology staining of in vivo rabbit experiments with obvious regeneration of upper 
hyaline cartilage and enhanced formation of new subchondral bone after three 
months.  
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1.1.4 Conclusion and expectation  
The 3D network structure, high water-content, readily adjustable mechanical 
properties, and inherent biocompatibility ensure that hydrogels possess high 
suitability as biomaterials. Although much research concerning hydrogels being 
used as biomaterials has been reported, how to realise controllable material 
properties in a straightforward and cost-effective manner remains a challenge. 
Issues including controllable mechanical properties, controllable polymer 
degradability and gelation time must be addressed and optimised to target 
particular applications. Exploiting new modes of polymer crosslinking or further 
optimising existing crosslinking procedures is necessary to solve these issues. 
For tissue engineering, creating a suitable matrix that forms a hydrogel of 
appropriate mechanical strength, degradability and biocompatibility and induces 
cell proliferation and differentiation is extremely important. However, as 
introduced above, creating a universal material that can fit all applications is likely 
to be unfeasible due to the complexities and variety associated with the various 
parts of the body. Consequently, biomaterial design must be highly tailored for 
the specific application.  
In this project, hyaluronic acid-based hydrogels will be investigated as cell-
friendly materials that have potential biomedical applications, including entities 
forwound healing management and osteoarthritis therapy. 
1.2 HA hydrogels  
1.2.1 Introduction to HA  
HA is a natural linear polysaccharide, made up of repeating disaccharide units 
(β-1,4-D-glucuronic acid and β-1,3-N-acetyl-D-glucosamine) as presented in 
Figure 1.11. As a major constituent of the extracellular matrix, it is found 
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throughout the body from eyes to cartilages and has drawn considerable attention 
as a biomaterial. Its non-sulfated glycosaminoglycan structure and highly 
hydrated polyanionic status in vivo provided its unique biological functions in 
cellular blocking and signalling, biocompatibility, anti-adhesion, hydrophilicity, 
biodegradability, and non-immunogenicity.(81) 
 
Figure 1.11 Repeat unit of Hyaluronic acid molecule. 
1.2.2 HA-based hydrogels as  Biomaterials  
1.2.2.1 HA in maintaining bioactivity  
Maintaining the bioactivity of native substances that exist in the extracellular 
matrix (ECM), including growth factors (84), peptides (85) and enzymes (86), that 
are necessary in regulating the metabolism of microorganisms and offering 
nutrition is a key aim of tissue regeneration. Silva et al. prepared a cellulose 
nanocrystals (CNCs) reinforced injectable HA hydrogel through hydrazone 
reaction between hydrazide-HA and aldehyde-HA/aldehyde-CNCs. This reaction 
also promoted an adjustable gelation time from 2.7±0.6 s to 127±31.3 s at room 
temperature depending on the component ratios. Through increasing the CNC 
content from 0% to 0.5 wt.%, significant prolonged release of vascular endothelial 
growth factor (VEGF) and platelet-derived growth factor (PDGF) were both 
realised from 2 days (0% CNCs)  to 12 days (0.375 wt.% and 0.5 wt.% CNCs). 
The GFs stability within the hydrogels was also similar during 21-day cultivation 
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in basal medium, evaluated through the western blotting method.(84)  However, 
a slight decrease appeared with the incorporation of aldehyde-CNCs.  
Arginylglycylaspartic acid (RGD), a cell-binding peptide, was also introduced into 
HA hydrogel scaffolds and reported to improve cell attachment.(85) For example, 
oligopeptide (Glycine)4-Arginine-Glycine-Aspartic acid-serine (G4RGDS) was 
grafted onto pectin molecules and made into composite hydrogels with hyaluronic 
acid by Chen et al.(85) Primary porcine auricular chondrocytes were chosen for 
in vitro experiments and rat models were carried out for in vivo tests to investigate 
chondrocyte proliferation, differentiation (collagen type I) and chondrogenic 
marker gene expression (collagen type II and aggrecan). Significant 
improvements in collagen type II and aggrecan expression were observed in 
RGD-containing hydrogels after 21 days in vitro evaluation, compared with pure 
hyaluronic acid/pectin hydrogels in their optimised groups (5/5 weight ratio of 
hyaluronic acid/pectin), which proved the effectiveness and maintained activity of 
RGD in this hyaluronic acid matrix hydrogel.  
1.2.2.2 HA as a soft tissue anti-adhesive  
The polymeric network of HA hydrogels can enhance the free post-surgical 
movement of some soft tissues without impeding the diffusion of drugs, nutrients 
and metabolic bio-waste in vivo.(87-89) To eliminate postoperative peritoneal 
adhesion and subsequent complications, research into an injectable thermo-
responsive hydrogel based on HA or similar carbohydrate-structure matrix, which 
presented great anti-adhesion property in animal experiments, has been 
conducted.(87-88) Through introducing poly(N-isopropylacrylamide)  (PNIPAm, 
a thermal sensitive polymer) into the hydrogel system, a thermal gelled copolymer 
of HA/chitosan/PNIPAm (HA-CS-PNIPAm) was obtained during a heating 
process from 20 °C to 50 °C. A dramatic increase in storage modulus was 
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recorded from 0 (<30 °C) up to ~320 Pa (~42 °C) in HA-CS-PNIPAm hydrogel 
with a 3.1 times higher storage modulus value than the pure PNIPAm control 
hydrogel at 37 °C.(87) Injectable gelation in vivo was then successfully achieved 
based on this excellent thermo-responsive property and hydrogel membranes 
formed upon HA-CS-PNIPAm copolymer solution (10%, w/v) injection into 
sidewall defect-cecum abrasion rat models. An obvious reduction in peritoneal-
intestinal adhesion was observed after 2-week tracing, compared with pure 
PNIPAm  and the untreated control. This material has great potential for clinical 
therapy in either intraabdominal or gynecologic surgery.  
1.2.2.3 HA as a 3D cell culture scaffold   
Growing cells in a 3D environment to mimic native tissues in the living body is 
valuable to research for biomedical engineering, and a lot of hyaluronic acid-
based hydrogels have been studied with the aim of creating a 3D 
microenvironment.(90-93)  
Poly(Nɛ-acryloyl-L-lysine)/hyaluronic acid (pLysAAm/HA) hydrogels were 
successfully prepared through photo-polymerisation and revealed increased 
MCF-7 breast cancer cell adhesion from ~50% (2D cell culture on tissue culture 
plates) to ~70% (3D culture in pLysAAm/HA hydrogels) after 4 hours.(90) 
Overexpression of proangiogenic growth factors, improved cell migration and 
penetrating abilities were observed in vitro after 7 days when cells were cultured 
in pLysAAm/HA hydrogels, and a significantly expanded volume of implant 
tumour in mice after 30 days was observed. This material provided a mimetic 
microenvironment for breast cancer research, however, further studies 
concerning the extent that the material affects gene secretion of other cell types 
and the related diseases would also be of value.  
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Stem cell growth has also been studied in 3D culture. Through radical 
polymerisation of methacrylated hyaluronic acid (HA-MA) under the existence of 
thiolated heparin (Hep-SH), which behaved as chain transfer agent, Gwon et al. 
formed Hep-HA hydrogels and investigated the spreading, proliferation, and 
migration of adipose-derived mesenchymal stem cells (ADSCs) in 3D 
cultivation.(91) They found that soft Hep-HA hydrogels (2 wt.% polymer) were 
more effective than stiff Hep-HA hydrogels (5 wt.% polymer) for ADSCs 
proliferation and migration, and provided the most suitable environment of all test 
groups, including tissue culture plates. The ability to maintain the function of 
ADSCs was proved by slightly increased or continuous mRNA expression of the 
pluripotency markers (Oct4, Sox2, and SSEA4) of  ADSCs in soft Hep-HA 
hydrogels during 1 week, compared with decreased expression in other groups. 
The selectivity of this hydrogel for ADSCs was also confirmed by comparing with 
human osteoblast cell line (MG63) that MG63 in Hep-HA hydrogels maintained 
spherical morphology and some death of MG63 cells were observed, indicating 
that Hep-HA hydrogels cannot support MG63 proliferation and further suggesting 
that individual material design is required for different cell types.  
1.2.2.4 HA as a joint tissue lubricant 
Composed of glucuronic acid and glucosamine units, HA presents mild 
degradability without releasing any harmful substance during hydrolysis. The 
wide existence of HA is not limited to the ECM, it is also the main component of 
synovial fluid, which offers HA promise as a lubricant to reduce cartilage and bone 
abrasion for osteoarthritis (OA) treatment. Feng et al. found that HA hydrogels 
can reduce OA symptoms of rats after 28 days in vivo compared with PBS 
solution.(93) They also found that negatively charged sulfate-modified HA 
hydrogels have improved therapeutic effectiveness compared to pure HA 
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hydrogels, with a smoother articular surface and closer thickness compared to 
healthy cartilage as observed through histology staining. A higher sulfated 
content of 2.86% (elemental percentage of sulfur) to each HA molecule provided 
a better condition for chondrogenesis promotion and hypertrophy suppression of 
encapsulated human mesenchymal stem cells, compared with low-sulfated 
content of 1.61% (elemental percentage of sulfur) in vitro, and also prolonged 
degradation of HA hydrogels.  
1.2.3 Structure-property of HA-based hydrogels in therapeutic use 
HA batches of various molecular weights and concentrations are applied to 
different applications areas due to differences in the polymer properties. A broad 
range of molecular weights from 100 KDa to 8,000 KDa are found throughout 
human body. However, it is difficult to determine the particular variant of HA for a 
specific application due to such variations.(94-95) General commercial 
categories of HA in terms of molecular weight and dosage, and the consequent 




Table 1.1 and Table 1.2. This information is provided by Bloomage Bio 
Technology Corporation Limited (Freda@) who conduct extensive research to 
create hyaluronic acid-based products for skin care applications such as 
moisturisers, anti-aging and skin regeneration treatments, and injectable 
hyaluronic acid gels. Professional and systematic work is presented on the official 
website of Freda@.(94-95)  





Table 1.1 Functions of hyaluronic acid with different molecular weight. 
Molecular weight (kDa) HA hydrogel applications 
≤10 
Trans-dermal absorption, deep hydrating, anti-
ageing, repairing skin damage 
10~1,000 Nourishing the skin, long-lasting moisturizing 
≥1,000 
Lubricating and film-forming, moisturizing, 
preventing skin damage, thickening and 
keeping emulsion stable 
 
Table 1.2 Functions of hyaluronic acid in different dosage. 
Dosage HA hydrogel applications 
0.1% ~ 0.5% for HA powder 
cream, emulsion, essence, lotion, gel, 
facial mask, etc. 
10% ~ 50% for HA solution  lipstick, eye shadow, foundation, etc. 
1%~5% for Hyacross facial cleaner, body wash, etc. 
0.5%~1% cation HA 
shampoo, hair conditioner, styling gel, 
hair restorer, etc. 
This project uses a 1,200 kDa Hyaluronic acid powder product as a matrix for the 
formation of hydrogels containing  different HA concentrations., Hydrogel 
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mechanical properties and microstructure are evaluated to ensure suitable 
porosity for cell growth and bioactive substance transfer, which are essential if 
the material is to be used for the growth and proliferation of cells. 
The choice of crosslinker is another crucial factor in hydrogel preparation. Many 
naturally-occurring macromolecules such as DNA,(67) peptides(85) and 
enzymes(86) have been studied as biosensors, or to maintain cell bioactivity. 
However, the high cost of these naturally-occurring products renders relatively 
low-cost PEG  a popular chemical crosslinker to form HA hydrogels with 
promising biomedical potentials that can achieve adjustable swelling ratio, 
rheological properties and degradation time.(96) Unsaturated carbon-carbon 
double bonds were introduced into the backbone of hyaluronic acid and mixed 
with thiol-terminated PEG to prepare chemical hydrogels through photo-
polymerisation, using Darocur 2959 (D-2959, 2-hydroxy-1-[4-(hydroxyethoxy) 
phenyl]-2-methyl-1-propanone) as the initiator. The results revealed that 
increased molar ratio of thiol/acrylate increases the swelling ratios of the 
hydrogels and increases the degradation time from 2 days to 7 days.(96) 
Furthermore, a secondary network can also be designed and achieved in a pre-
PEG-HA hydrogel. For example, in a tannic acid/PEG crosslinked HA hydrogel 
system, increased  storage modulus, cell attachment and proliferation of L929 
mouse fibroblast cell line, anti-oxidant capacity were observed when immersing 
the PEG crosslinked hydrogels in variable concentrations of tannic acid for 2 days 
(from 0 to 0.15% (w/v).(97)  The exploitation of low-cost, and multifunctional 
crosslinkers that enable HA-based hydrogels to be created with stimuli-
responsive behaviours is a key concept to this project.  
1.2.4 Summary 
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Biopolymer-based hydrogels have been widely used  as effective biomaterials in 
recent years. Many bioactive substances that mimic the extracellular 
microenvironment, and different cross-linkers, have been studied to realise 
hydrogels that possess appropriate requirements for particular biomedical 
applications. In particular, HA demonstrates great potential as a cell-friendly 
macromolecule that may be exploited as a scaffold for cell growth and 
proliferation. However, consideration for material design to match the specific 
application is imperative because (1) Some HA hydrogels demonstrate less than 
optimal cell attachment, (2) Some HA hydrogels cannot support ADSCs 
attachment despite HA having a CD44+ receptor, and (3) the mechanical 
properties of the hydrogel may not suitable for cell adhesion.(91) Consequently, 
it is important that new HA-based hydrogels are devised and generated for 
particular biomedical applications. 
This project will focus on creating hyaluronic acid hydrogels for biomedical 
applications based on the three basic requirements which were brought up by 
Wichterle and Lím when they  applied hydrogels to biological use, (i) a structure 
containing the desired water content; (ii) inertness to normal biological processes 
(i.e. resistance to unfavourable reactions in the organism); (iii) permeability for 
metabolites.(1) 
HA-based hydrogels that possess stimuli-responsiveness for chronic wound 
management and diagnosis are reported in Chapter 2. The design of this material 
was focused on the redox reaction between disulfide bridges present in the 
crosslinker, and thiol groups present in the target molecule glutathione (GSH).  
Changes in the hydrogel mechanical properties, network stability and morphology 
were assessed, before an investigation into how mechanical properties of these 
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hydrogels could be reinforced to mimic biomineralisation for bone repair (Chapter 
3).  
Injectable hydrogels were created for potential use in the repair of joint tissue. In 
material design, physical crosslinking was introduced into the reaction system to 
build up metal-polymer networks, notably an iron(III)-HA network. To reduce the 
cytotoxicity of Fe3+ and stabilise thiol groups in bioactive molecules, a cell friendly 
Iron(III)-glutathione complex was prepared in an additive-free way and 
characterised  (Chapter 4). This complex successfully acted as a physical 
crosslinker that connected hyaluronic acid macromolecules, forming networks 
with increased viscosity and storage modulus. The injectable physical hydrogel 
reported has great potential for the facilitation of tissue regeneration (Chapter 5).  
Both chemical and physical HA-based hydrogels were studied in this work and 
further details of these promising biomaterials are discussed in the following 
chapters.  
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Chapter 2  
A glutathione-responsive hyaluronic acid-based hydrogel 
for chronic wound management 
▪ This chapter has been published. Reference [Gao, Z., Golland, B., Tronci, 
G. and Thornton, P.D. 2019. A redox-responsive hyaluronic acid-based 
hydrogel for chronic wound management. Journal of Materials Chemistry 
B. 7(47), pp.7494–7501.] 
Polymer-based hydrogels have been widely applied for chronic wound 
therapeutics, due to their well-acclaimed wound exudate management capability. 
At the same time, there is still an unmet clinical need for simple wound diagnostic 
tools to assist clinical decision-making at the point of care and deliver on the 
vision of patient-personalised wound management. To explore this challenge,  a 
one-step synthetic strategy to realise a redox-responsive, hyaluronic acid-based 
hydrogel that is sensitive to wound environment-related variations in glutathione 
(GSH) concentration is presented. By selecting aminoethyl disulfide (cystamine) 
as a GSH-sensitive crosslinker and considering GSH concentration variations in 
active and non-self-healing wounds, the impact of GSH induced cystamine 
cleavage on hydrogel dimensions was investigated with the aim to build GSH-
hydrogel dimension relationships for potential point-of-care wound diagnosis. The 
hydrogel obtained was also found to be non-cytotoxic and aided L929 fibroblast 
growth and proliferation over seven days in vitro cell culture study. Such a 
material offers a very low-cost tool for the visual detection of a target analyte that 
varies dependent on the status of the cells and tissues (wound detection), and 
may be further exploited as an implant for fibroblast growth and tissue 
regeneration (wound repair). An overall illustration of this hydrogel for wound 
management process is presented in Figure 2.1.  
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Figure 2.1 Illustration of GSH-responsive HA hydrogel for wound management. 
The hydrogel diameter change as increasing GSH concentrations can be 
observed by naked eyes.  
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2.1 Introduction 
Polymeric hydrogels have emerged as highly promising materials for a range of 
biomedical applications, including carriers for controlled drug delivery,(98-100) 
protein adsorption,(101)  the creation of contact lenses,(102-103) and as 
injectable implants.(104-105) The water-dominated composition of hydrogels 
renders them suitable for deployment in vivo, ensuring that such non-cytotoxic 
materials are also excellent candidates for use as scaffolds that facilitate tissue 
regeneration.(106-109) In addition, hydrogels that undergo an actuated change 
in dimensions in response to a target analyte may act as biosensors. Such 
materials have been deployed for the detection of bacterial enzymes,(110) 
toxins,(111) disease specific genes,(112) and pathogenic proteins that are 
associated with particular disease states.(113) Polymer hydrogels therefore hold 
great promise as materials for chronic wound management, both for the detection 
of chronic wound-associated markers as a mode of diagnosis, and by providing 
a scaffold for fibroblast growth, and subsequent new tissue generation, as part of 
wound healing.  
Chronic states, such as those associated with non-self-healing ulcers, exhibit 
excessive oxidant stress, leading to upregulated reactive oxygen species 
(ROSs), inhibited cell migration and proliferation, and growth factor 
deficiency.(114) Whilst antioxidants regulate endogenous oxidant production in 
active wounds so that repair occurs via an orderly process, non-self-healing 
ulcers are in a persistent inflammation state, whereby prolonged infiltration of 
polymorphonuclear leukocytes and mononuclear cells results in reduced 
concentration of antioxidants, for instance GSH, and incorrect redox potential in 
the cells.(115) Tracking biochemical shifts, such as antioxidant concentration, 
could therefore be useful to diagnose changes in wound chronicity and assist with 
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clinical decision making. Given that wound diagnosis relies on clinical 
assessment,(116) hydrogels with inherent oxidation responsivity could play a 
significant role as a cost-effective point-of-care diagnostic system. Following 
hydrogel contact with the wound, oxidation-induced changes in hydrogel size 
could be exploited to describe defined chronic wound states and inform clinical 
therapies. 
Hyaluronic acid (HA), a natural polysaccharide that is a major constituent of the 
ECM, offers biocompatibility, anti-adhesion, biodegradability, and non-
immunogenicity.(117) HA content within the human body is approximately 15 g 
(for a 70 kg human), and largely resides in the skin and musculoskeletal 
tissue.(118) The hydrophilicity of HA ensures that it is an excellent candidate for 
use as a gelator within both physical(119) and chemical hydrogels.(120)  HA-
containing hydrogels have been reported as effective scaffolds for the 
regeneration of bone,(121) cartilage,(122) neural tissue,(123) and myocardial 
tissue.(124) In direct relation to wound healing, recent examples of HA-based 
chemical hydrogels include an anti-oxidative and anti-inflammatory drug release 
system for early tendinopathy intervention,(125) an in situ-forming biomimetic 
dressing for soluble factor-free wound healing,(126) a UV-cured drug-
encapsulated antibacterial hemostat,(127) and injectable hydrogels for the 
management of osteoarthritic synovial fluids.(128)  However, despite substantial 
efforts being afforded to the employment of HA as a component of a therapeutic 
system, limited reports have proposed the application of HA for chronic wound 
diagnostics, whereby expensive and sophisticated imaging apparatus are 
required.(129) 
GSH, a natural tripeptide that consists of gamma linked glutamate, cysteine and 
glycine as shown in Figure 2.2, is abundant in the majority of animal cells. GSH 
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plays a key role in biological processes including biocatalysis, metabolism, signal 
transduction, gene expression, apoptosis and anti-oxidation.(130) GSH is 
present in both its reduced (GSH) and oxidized state (GSSG), and the ratio of the 
two variants dictate many pharmacological processes within the cell. The thiol 
that the cysteine unit presents ensures that GSH is a reducing agent and offers 
a signal for GSH detection.(131) The intracellular concentration of GSH is 
typically 0.5 mM for normal cells, compared to 10 mM for cancerous cells.(132) 
On the other hand, averaged GSH levels were found to be lower in diabetic foot 
ulcers, in line with the excessive oxidant stress in the former case.(133) 
Consequently, materials that are able to respond to GSH concentrations within 
this range hold great promise for the detection of pathological GSH 












Glutamate                 Cysteine           Glycine  
Figure 2.2 Molecular structure of glutathione reduced. 
This chapter described the facile, one-step synthesis of a HA-based chemical 
hydrogel that is spatially responsive to the presence of GSH. Aminoethyl disulfide 
(cystamine) is employed as a dynamic covalent crosslinker that is sensitive to the 
presence of GSH; cystamine-GSH conjugation results in crosslinker cleavage, 
increased hydrogel swelling and a clearly visible change in hydrogel dimensions. 
The hydrogel was found to be non-cytotoxic and aided fibroblast growth and 
proliferation over seven days. Such a material offers a very low cost method for 
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the visual detection of a target analyte that varies dependent on the status of the 
cells and tissues (wound detection), and may be further exploited as a scaffold 
for fibroblast growth and tissue regeneration (wound repair). 
2.2 Materials and methods 
2.2.1 Materials 
HA sodium salt (molecular weight: 1,200 kDa, cosmetic grade) was purchased 
from Hollyberry Cosmetic, 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-
morpholinium chloride (DMTMM) and 2-(N-morpholino) ethanesulfonic acid 
(MES) were purchased from Fluorochem. cystamine, rhodamine B 
isothiocyanate-dextran (RITC-dextran) and ninhydrin reagent were purchased 
from Alfa Aesar. alamarBlueTM assay kit was purchased from ThermoFisher 
Scientific. All other reagents were purchased from Sigma-Aldrich.  
2.2.2 Preparation of hyaluronic acid hydrogels 
HA powder was dissolved in deionised water to prepare a 2 wt.% HA solution. 
MES buffer (0.1 M) was added at room temperature under stirring to provide a 
weak acid environment (pH 5.5). DMTMM (2 equivalents per HA repeat unit) was 
then added at 37 °C to activate the carboxyl groups of HA. The temperature was 
maintained at 37 °C for 1 hour, and a molar ratio of either 0.2 or 0.4 moles of 
cystamine relative to the moles of each HA repeat unit was added to the solution 
(Table 2.1). The stirring speed was increased to 1,000 r·min-1 for 5 minutes and 
either 0.6 g or 0.8 g of the reacting solution was cast into either 12- or 24-well 
plates, respectively. HA hydrogels were obtained after 2-hour incubation at 37 
°C. 
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Table 2.1 The quantities of reagents used to make two covalent hydrogels. 
Sample ID HA (wt.%) Cystamine (mol.% of HA) 
C2-20 2.0 20.0 
C2-40 2.0 40.0 
 
2.2.3 Analysis of HA crosslinking 
Attenuated total reflectance fourier transform infrared (ATR-FTIR) spectroscopy 
was used to characterise the crosslinked structure of HA hydrogels. IR spectra 
were obtained from freeze-dried networks and recorded between 4000 cm-1 and 
500 cm-1 using a Bruker spectrophotometer at room temperature.  
The thermal properties of both HA and the freeze-dried networks produced were 
evaluated by differential scanning calorimetry (DSC) using a DSC Q20 unit (TA 
instruments) calibrated with indium. DSC thermograms were recorded under 
nitrogen atmosphere with a heating rate of 10 °C·min-1 from 30 °C to 200 °C. 
The progress of the crosslinking reaction was investigated by 2,4,6-
trinitrobenzenesulfonic acid (TNBS) and ninhydrin assays.(134-135) TNBS was 
used to quantify any unreacted cystamine entrapped in the crosslinked network. 
0.8 g of newly-synthesised hydrogel was freeze-dried and immersed in 2 mL 
NaHCO3 (4 wt.%) at 40 °C for 30 minutes to wash away any unreacted cystamine; 
1.0 mL of the supernatant was collected and investigated by TNBS assay. 1.0 
mL TNBS solution (0.5 wt.%) was added to the supernatant in the dark and 
incubated at 40 °C for 3 hours with a rotation speed of 120 r·min-1. 3 mL HCl (6 
N) was added to the incubated solution and the temperature raised to 60 °C for 
1 hour to terminate the reaction. After solution equilibration to room temperature, 
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the sample solutions were diluted with 5 mL H2O. The unreacted TNBS was 
washed out by extraction with 20 mL diethyl ether, three times. 5 mL of the 
retrieved sample solution was immersed in hot water (~60 °C) in a fumehood to 
evaporate any diethyl ether, and diluted with 15 mL H2O. Finally, 2 mL of solution 
was analysed by UV-Vis spectroscopy at 346 nm. Quantification of any cystamine 
residue was carried out by comparison with an cystamine calibration curve 
(calibration equation: y=0.0666x-0.0184, R2=0.9933, y=absorbance, x= 
cystamine concentration, mM).  
The presence of any terminal free amino group deriving from the grafting, rather 
than the complete crosslinking, of HA with cystamine was quantified by ninhydrin 
assay. 10 mg of washed, freeze-dried polymer was immersed in 1 mL water. 1 
mL ninhydrin solution (8 wt.%) was then added in the dark, and the solution 
quickly immersed in a water bath at 95 °C for 15 minutes. 1 mL ethanol was 
added to stop the reaction after equilibration at room temperature. A calibration 
curve was obtained by measuring UV-Vis absorbance at 348 nm using various 
amounts of glycine. 
2.2.4 Hydrogel swelling and degradation studies 
Newly-synthesised hydrogels were weighed (mw) and then immersed in 
deionised water. As control samples, another series of hydrogels was soaked in 
H2O with 5 mM GSH to determine any hydrogel response. The mass of the 
samples (mt) was recorded at selected time points (1, 2, 3, 4, 7, 14, 21, 28 days) 
following light sample blotting with tissue paper. The swelling ratio (SR) of each 
hydrogel was calculated using the following Equation 2.1: 
𝑺𝑹 =  
𝒎𝒕
𝒎𝒘
× 𝟏𝟎𝟎 Equation 2.1 
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Hydrogel degradability was evaluated via gravimetric analysis of the covalent 
networks following incubation in aqueous solutions and drying. The initial network 
mass of hydrogel C2-20 was recorded as m0. 0.8 g of hydrogel C2-20 was 
immersed in PBS solution either with GSH (5 mM) or without GSH. Samples were 
collected following 1, 2, 3, 4, 7, 14, 21 and 28 days, washed with deionised water, 
freeze-dried and weighed (md). The percentage of the crosslinked network 
remaining (µrel) was calculated via the following equation: 
𝝁𝒓𝒆𝒍 =  
𝒎𝒅
𝒎𝟎
× 𝟏𝟎𝟎 Equation 2.2 
 
2.2.5 Mechanical tests 
Hydrogels were tested using a rheometer (Anton Paar, MCR 302) with a 25 mm 
parallel plate. Frequency sweeps were recorded at 100-1 rad·s-1 with a constant 
amplitude (1%) at room temperature, using a 0.8 g hydrogel and a 2 mm gap. 
Time sweep measurements were carried out to quantify hydrogel gelation 
kinetics following the reaction of HA with cystamine. 0.6 mL of solution was 
injected homogenously on the sample holder and tested with a 25 mm parallel 
plate. The measurement was carried out at 37 °C over 150 minutes with constant 
amplitude (1%) and frequency (5 Hz).  
Compression measurements were conducted using Bose ELF 3200 apparatus. 
All the hydrogel samples (Ø: 3 mm; h: 3 mm) were tested with a compression 
speed of 0.02 mm·s-1.  
2.2.6 Scanning electron microscopy (SEM) 
The network microstructure of newly-synthesised and partially-degraded 
networks was inspected by SEM using a JEOL JSM6610LV microscope under 5 
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kV voltage following gold coating. Freeze dried samples were collected following 
either synthesis or 2-day immersion in 20 mL solution of either PBS or GSH (5 
mM)-supplemented PBS. Pores (n=20-60) were visualised and their diameter 
measured through Image J software. 
2.2.7  Macromolecule uptake studies 
Hydrogels were loaded with RITC-dextran (Mn: 70,000 g·mol-1, Alfa Aesar), as a 
model macromolecule. 0.6 g hydrogel was immersed in 2 mL RITC-dextran-
containing (0.5 mg·mL-1) PBS solution at 37 °C for 24 hours. Samples were 
washed with PBS solution to remove any surface-coated RITC-dextran before 
being transferred into 3 mL PBS solution that contained various GSH 
concentrations (0-20 mM). RITC-dextran uptake was calculated through the 
difference in supernatant absorbance before and after RITC-dextran loading 
(calibration equation: y=0.0011x-0.004, R2=0.9995, y=absorbance, x= RITC-
dextran concentration (µg·ml-1)). 
The change of hydrogel network structure, and the distribution of RITC-dextran 
loaded in the hydrogel, was investigated by analysis of the lyophilised networks 
of hydrogels that had undergone incubation in PBS solution that contained or 
lacked SH at 37 °C, by laser scanning confocal microscopy (LEICA TCS SP8, 
excitation wavelength 552 nm). 
2.2.8 Hydrogel response to simulated wound fluid 
Simulated wound fluid (SWF) was prepared as reported.(136) Briefly, 5.844 g 
sodium chloride (NaCl), 3.360 g sodium hydrogen carbonate (NaHCO3), 0.298 g 
potassium chloride (KCl), 0.278 g calcium chloride (CaCl2) and 33.00 g bovine 
serum albumin (BSA) were dissolved into 1 L of deionized water. 0.6 g of hydrogel 
was immersed in 20 mL SWF loaded with varied GSH content (0-20 mM) to mimic 
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multiple wound chronic states. All the samples were incubated at 37 °C, stirred 
at 100 r·min-1 and any change in hydrogel size recorded by eyes and optical 
images following 24-hour incubation. 
2.2.9 Cytotoxicity evaluation 
Hydrogel (8 mm3) was incubated in 70 wt.% ethanol (×3), and then washed in 
PBS buffer (×3), and ultimately in cell culture medium (×3). L929 murine 
fibroblasts were cultured (37 °C, 5% CO2) in Dulbecco’s modified eagle medium 
(DMEM) supplemented with 10 vol.% fetal bovine serum (FBS) and 0.5 vol.% 
penicillin–streptomycin. The cell suspension (1×104 cells·mL-1) was transferred 
to a 96-well-plate (200 µL·well-1), followed by application of individual hydrogel 
samples to each well. Cell viability was quantified by alamarBlueTM Assay after 
1-7-day culture following the product protocol from ThermoFisher. Cells cultured 
on either tissue culture plates (TCPs, positive control) or non-treated tissue 
culture plates (NTCPs, negative control) were set as a positive control and a 
negative control, respectively.  
2.2.10 Statistical analysis 
For statistical analysis, all the cytotoxicity results were analysed at least three 
times. The significant difference was calculated through One ANOVA analysis 
with a p level at 0.05. The results are presented as *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 
0.001, ****p ≤ 0.0001.  
2.3 Results and discussion 
Chemical hydrogels were successfully generated from a 2 wt.% HA aqueous 
solution by crosslinking HA with either 20 mol.% (C2-20) or 40 mol.% (C2-40) 
cystamine, with respect to HA carboxylic acid groups (Figure 2.3). 
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Figure 2.3 Schematic illustration of hydrogel formation and redox-reaction. The 
reaction between cystamine and HA chains yields a crosslinked polymer 
that forms a chemical hydrogel when maintained in aqueous solution. GSH-
induced cystamine disulfide reduction disrupts the crosslinked network, 
resulting in changes to the hydrogel dimensions and mechanical properties. 
Qualitative confirmation of HA crosslinking was achieved by FTIR spectroscopy 
(Figure 2.4); the spectrum of the crosslinked networks revealed a peak at 1700 
cm-1, which corresponds to the amide bonds formed between HA and cystamine. 
In addition, the peak present at 538 cm-1 in the crosslinked samples is attributed 
to the presence of disulfide bonds that are present within cystamine molecules. 
For C2-20, TNBS and ninhydrin assays revealed that 82 mol.% of cystamine 
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amine groups had reacted to form a complete covalent crosslink, rather than 
forming cystamine -grafted residues. In the case of C2-40, 61 mol.% of amine 
groups presented by cystamine had reacted.  
 
Figure 2.4 FTIR spectrum of HA (top), hydrogel C2-20 (middle) and C2-40 
(bottom). Red squared the peaks that confirm successful HA 
functionalisation. 
DSC analysis revealed broad endothermic peaks from 63.6 °C -80.9 °C that 
were attributed to water evaporation. The exothermic peak at 138.9 °C (C2-20) 
and 143.0 °C (C2-40) in the thermograms of the crosslinked polymers that were 
absent from the thermogram corresponding to HA (Figure 2.5). These additional 
peaks may be ascribed to the thermal decomposition of the cystamine 
crosslinks. 
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Figure 2.5 DSC thermograms corresponding to the crosslinked polymer used to 
form C2-20 (top) and C2-40 (middle), and linear HA. 
Rheometry was carried out to investigate the kinetics of the crosslinking reaction. 
Rheograms revealed that C2-20 was formed with a storage modulus (G’) of 885 
Pa and a loss modulus (G’’) of 9 Pa after 130 minutes (Figure 2.6), whilst C2-40 
was formed with a G’ of 1029 Pa and a G’’ of 13 Pa after 140 minutes (Figure 
2.6). The value of G’ in sample C2-40 was slightly higher than C2-20, which might 
suggest a higher crosslinking density.  
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Figure 2.6 Rheological analysis during HA crosslinking to assess gelation 
kinetics for C2-20 (blue) and C2-40 (grey). The solid line corresponds to G' 
and the dash line corresponds to G”. 
Results of both C2-20 and C2-40 confirmed that the hydrogels can be created in 
a simplie manner within a relatively short timeframe; the gel hardening times 
displayed by hydrogels formed from reacting mixtures containing cystamine may 
be attributed to the occurrence of grafted rather than crosslinked HA chains, as 
supported by TNBS and ninhydrin results. These results give indirect evidence of 
the impact that the HA/cystamine molar ratio has on the network crosslinking 
yield. Overall, rheological analysis revealed that the storage modulus of both 
crosslinked materials exceeded the loss modulus. This confirmed their 
classification as hydrogels that storage modulus appeared higher than loss 
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modulus in rheology and the formation of a solid-like hydrogel rather than a 
viscous liquid (Figure 2.7). 
 
Figure 2.7 Frequency sweep rheological analysis revealing the storage (G’) and 
loss (G’’) modulus of hydrogel C2-20 (a) and C2-40 (b). 
Due to the superior crosslinking efficiency, hydrogel C2-20 was chosen for further 
investigations concerning its swelling capabilities, and its susceptibility to 
disassemble in the presence of the target analyte, GSH. When incubated in 
deionised (DI) water, newly-synthesised C2-20 displayed a 700 wt.% mass 
increase after 21 days (Figure 2.8a). In contrast, when incubated in the presence 
of aqueous GSH solution (5 mM), C2-20 started to break and could not be 
weighed after two days owing to the fragility of the material. This strongly 
advocates that GSH-induced cleavage of the disulfide bonds in cystamine-
crosslinked HA chains occurs, resulting in the disintegration of the covalent 
network due to GSH-cystamine bond formation (Figure 2.3). The mass of 
lyophilised polymer that had been maintained as a hydrogel in aqueous solution 
that contained GSH was greater than the mass of polymer that had previously 
been maintained as a hydrogel in aqueous solution that lacked GSH (Figure 
2.8b). The difference in the mass of recovered polymer is credited to GSH 
conjugation to the HA backbone. After four days storage in GSH solution the 
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hydrogel could not be recovered, rendering lyophilisation and subsequent mass 
recording was impossible. 
 
Figure 2.8 Hydrogel C2-20 swelling (a) and degradation (b) in DI water (black 
line) versus C2-20 swelling in aqueous GSH solution (5 mM, red line).  
Next, the compression properties of C2-20 were investigated. C2-20 exhibited 
great compressibility as evidenced through stress-compression curves (Figure 
2.9a), which was usually applied to evaluate the compressive property of 
materials. Following 48-hour incubation in GSH (5mM)-supplemented PBS 
solution, the stress at break of C2-20 was significantly lower than the stress at 
break of both the newly-synthesised C2-20, and C2-20 following 48-hour 
incubation in GSH-free PBS solution (Figure 2.9b). The original hydrogel could 
hold up to 82% compression with stress at break of 90±8 kPa.  After being 
immersed in PBS for 48 hours, a slight decrease in stress at break was observed 
(b= 75±10 kPa) and the compression at break was also reduced to 80%. In the 
presence of GSH solution, a significant decrease in stress at break (b = 30 kPa), 
and compression at break (b= 62%) was observed after 48 hours, providing 
convincing evidence for GSH-mediated hydrogel disassembly.  
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Figure 2.9 (a) Stress-strain curves corresponding to C2-20, C2-20 stored in PBS 
buffer solution for 48 hours, and C2-20 stored in PBS buffer solution that 
contained GSH (5 mM) for 48 hours. (b) The breaking stress values of C2-
20, C2-20 stored in PBS buffer solution for 48 hours, and C2-20 stored in 
PBS buffer solution that contained GSH (5 mM) for 48 hours.  
The morphology of C2-20 incubated in PBS buffer or GSH-supplemented PBS 
buffer were assessed by SEM (Figure 2.10), to investigate whether GSH-induced 
network disintegration resulted in significant changes in material microstructure. 
SEM images of lyophilised hydrogels were captured following 48-hour incubation, 
at which point the GSH-treated material was no longer stable in hydrogel form. 
Clear differences in the morphologies of the two samples can be observed; in the 
absence of GSH, the material presents a predominantly smooth surface that 
largely lacks major defects, whereas in the presence of GSH the material 
contains substantial pores that are ascribed to GSH-mediated crosslinker 
cleavage (Figure 2.10 a and b, respectively). The freeze-dried internal structure 
of C2-20 is porous, with an average pore diameter of 58±18 µm (Figure 2.10c). 
The internal pore diameter of the GSH-treated (48 hours) hydrogel was found to 
be 176±89 µm after the same lyophilisation process as initial C2-20, whereby the 
greater pore size again supports the rationale for the degradation effect that GSH 
has on the crosslinked polymer structure (Figure 2.10d). 
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Figure 2.10 SEM images of C2-20 after 48-hour incubation in either PBS solution 
(a, c), or GSH-supplemented PBS solution (5 mM) (b, d). Scale bar: 100 µm.  
In order to apply the hydrogel within a diagnostic setting, the uptake of RITC-
dextran by C2-20 was assessed by confocal microscopy. The hydrogels were 
incubated in RITC-dextran solution, prior to lyophilisation and analysis of the 
recovered polymeric network. When the hydrogels are incubated in greater 
concentrations of GSH, more extensive scaffold disruption, and increased gel 
porosity, arises due to the onset of network degradation. Consequently, the 
fluorescent marker is able to penetrate more readily in the partially-degraded 
network upon network cleavage induced by increasing GSH levels (Figure 2.11). 
The depth to which RITC-dextran was able to penetrate the hydrogel was related 
to GSH concentration, increasing from 125 µm (No GSH) to 200 µm (5 mM), 250 
µm (10 mM), up to 300 µm (20 mM GSH). 
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Figure 2.11 Confocal images of lyophilised C2-20 hydrogel network loaded with 
RITC-dextran in (a) PBS solution, and PBS solution supplemented with (b) 
5 mM GSH, (c) 10 mM GSH, and (d) 20 mM GSH. The stained polymer 
network is provided in the left-hand image of each box, and becomes 
increasingly disintegrated with increased GSH concentration. The depth to 
which RITC-dextran was able to penetrate the hydrogel was related to the 
fluorescence depth profile for each hydrogel and is provided in the right-
hand image of each box. Scale bar: 200 µm.  
The pronounced effect that GSH has on hydrogel swelling may also be exploited 
to realise a diagnostic device that undergoes dimension changes that are visible 
to the naked eye upon interaction with GSH. Figure 2.12 demonstrates the 
macroscopic changes in C2-20 swelling that occur when the hydrogel is 
incubated in simulated wound fluids that contain various concentrations of GSH, 
as a mimetic of varying chronic wound states. As anticipated, hydrogel swelling 
increases with increasing GSH concentration due to a reduction in the covalent 
crosslinks that originally maintain the hydrogel. Increasing the GSH concentration 
from 0 mM to 5 mM results in an increase in hydrogel diameter by ~43%. 
Increasing the solution GSH concentration from 0 mM to 10 mM results in the 
hydrogel diameter increasing by 63%, and increasing the GSH concentration 
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from 0 mM to 20 mM results in hydrogel dissolution (Figure 2.13). As average 
GSH levels are found to be lower in diabetic foot ulcers (53.4 pmol·mg-1 wet 
weight), compared to control tissues (150.6 pmol·mg-1 wet weight), material 
expansion would be a sign of healthy tissue. Conversely, elevated GSH levels in 
tumour tissue compared to healthy tissue, and the accompanying increase in 
hydrogel dimensions, may act as a simple diagnostic test for the exposure of 
cancerous cells.(137) 
 
Figure 2.12 C2-20 swelling upon interaction with GSH. The extent of swelling is 
linked to the GSH concentration in the simulated wound fluid in which the 
hydrogel was stored. The edges of the three-dimensional hydrogels are 
circled for clarity.  
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Figure 2.13 Dissolution of C2-20 after 24-hour immersion in the simulated wound 
fluid containing 20 mM GSH. The material was too fragile to undergo any 
form of analysis. 
To further probe the suitability of deploying C2-20 as part of a wound 
management device, the cytotoxicity of the material was assessed using the 
alamarBlueTM colorimetric assay for cell viability (Figure 2.14). It is essential that 
a diagnostic material is not detrimental to healthy cells in order to avoid false 
summations. Additionally, if the hydrogel is intended to be used in situ to aid 
wound healing whilst simultaneously providing diagnostic information, it is 
essential that the hydrogel promotes fibroblast growth and proliferation over an 
extended period. Cell viability is positively related to fluorescent intensity in the 
alamarBlueTM assay. L929 cells grew most rapidly on tissue culture plates 
(TCPs), in contrast to no cells surviving following culturing on non-treated tissue 
culture plates (NTCPs). The cells presented excellent proliferation in the 
presence of C2-20 up to 7 days; a significant increase in cell number was found 
for each progressive time point. Cell status on TCPs is shown in Figure 2.15, and 
Figure 2.16 demonstrates cell morphology on C2-20 from day 1 (Figure 2.16a) to 
day 7 (Figure 2.16d). L929 cells cultured on C2-20 continued to spread and 
proliferate for the duration of the experiment, confirming the suitability of using 
C2-20 as a material for wound diagnosis and to aid wound repair. 
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Figure 2.14 L929 cells viability after 7-day culture with hydrogel C2-20, on tissue 
culture plates (positive control) and non-treated tissue culture plates 
(negative control). 
 
Figure 2.15 Optical microscopy images of L929 fibroblast cells cultured on tissue 
culture plates for 1 day (a), 3 days (b), 5 days (c) and 7 days (d). 
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Figure 2.16 Optical microscopy images of L929 fibroblast cells cultured with 
hydrogel C2-20 for 1 day (a), 3 days (b), 5 days (c) and 7 days (d). 
2.4 Conclusion 
GSH-responsive, non-cytotoxic, HA-based hydrogels were prepared through the 
facile crosslinking of HA with cystamine. The hydrogels formed remained robust 
in aqueous solutions that lacked GSH, but lost structural integrity when incubated 
in solution that contained GSH. This GSH-induced change altered hydrogel 
properties both on microscopic and macroscopic levels. The distribution of RITC-
dextran within hydrogels that were incubated in the presence of GSH revealed 
amplified fluorescent probe distribution in correspondence with increased GSH 
concentrations. Hydrogel crosslinker cleavage by GSH had a sufficiently 
pronounced effect on the swelling properties of the hydrogel; increased hydrogel 
swelling upon interaction with GSH-supplemented simulated chronic wound fluid 
was evident to the naked eye. The hydrogel offers a highly simplistic, label-free, 
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method to monitor GSH concentration within a sample fluid, and may be used as 
a support for fibroblast growth and proliferation. Consequently, it is a promising 
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Chapter 3  
Hydrogen phosphate-mediated acellular biomineralisation 
within a dual crosslinked hyaluronic acid hydrogel  
▪ This chapter has been accepted for publication. Reference [Gao, Z., 
Hassouneh, L., Yang, X., Pang J., Thornton, P.D. and Tronci, G. 2020. 
Hydrogen phosphate-mediated acellular biomineralisation within a dual 
crosslinked hyaluronic acid hydrogel. European Polymer Journal. 
(Accepted)] 
The creation of hyaluronic acid (HA)-based materials as biomineralisation 
scaffolds for cost-effective hard tissue regenerative therapies remains a key 
biomedical challenge. A non-toxic and simple acellular method to generate 
specific hydrogen phosphate (HPO42-) interactions with the polymer network of 
cystamine crosslinked HA hydrogels is reported (Figure 3.1). Reinforced dual 
crosslinked hydrogel networks were accomplished after 4-week incubation in 
disodium phosphate-supplemented solutions that enabled the mineralisation of 
hydroxyapatite (HAp) crystals across the entire hydrogel structure. HPO42--HA 
hydrogen bond interactions were confirmed by attenuated total reflectance 
Fourier transform infrared spectroscopy (ATR-FTIR) and density functional 
theory (DFT) calculations. HPO42--mediated physical crosslinks proved to serve 
as a first nucleation step for acellular hydrogel mineralisation in simulated body 
fluid allowing HAp crystals to be detected by X-ray powder diffraction (2θ = 27°, 
33° and 35°) and visualised with density gradient across the entire hydrogel 
network. On a cellular level, the presence of “Z”-shaped aggregated structures 
proved key to inducing ATDC 5 cell migration whilst no toxic response was 
observed after 3-week culture. This mild and facile ion-mediated stabilisation of 
HA-based hydrogels has significant potential for accelerated hard tissue repair in 
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vivo and provides a new perspective in the design of dual crosslinked 
mechanically-competent hydrogels. 
 
Figure 3.1 Illustration of hydrogen phosphate-mediated acellular 
biomineralisation within HPO42- and cystamine dual crosslinked HA 
hydrogel.
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3.1 Introduction 
As the main component of ECM, HA has been applied widely in medicine, for 
example as a lubricant for osteoarthritis treatment(138-139), wound dressing 
material to support healing(140) and as post-operation adhesive(141). Recently, 
HA hydrogels have been applied as implants to support cell growth and aid 
regeneration of soft tissues including derm,(140) (142) mucosa(141) (143) and 
tendon(144-145), due to the biocompatibility, biodegradation profile and 
mechanical properties of HA. The advantageous features of HA in biology, as 
well as its chemical structure, which can be selectively targeted to fabricate 
mechanically-competent bioinspired scaffolds, have also been leveraged to 
support the regeneration of bone. However, this has frequently required either 
severe or sophisticated synthetic approaches to address the mechanical and 
composition requirements of bone. Although many methods have been 
investigated,(146-147) mild non-toxic routes enabling the fabrication of bone-like 
HA-based architectures have not yet been fully realised.  
Ionic interactions, particularly salt effects, enable biomacromolecule cross-linking 
in a mild manner that avoids chemical synthesis and/or extensive energy 
radiation.(148-149) The Hofmeister effect details the extent that protein solubility 
is altered by the presence of different salts in an aqueous environment, and may 
be used to design protein-based hydrogels with enhanced compressive and 
tensile properties.(150-151) The mechanism of salt effect in aqueous solutions 
has been explored in (i) hydration theories, (ii) electrostatic theories, (iii) van der 
Waals forces, and (iv) internal pressure concepts;(152) however, non-specific 
ion-mediated interactions may be applied universally in macromolecules.(153-
155) Barrett hypothesised that a particular salt could act as either a stabiliser (i.e. 
kosmotrope) or a destabiliser (i.e. chaotrope) for a specific macromolecule;(156) 
- 57 - 
for instance, alginate may be particularly well stablised by calcium.(157-159) 
Therefore, an investigation into whether phosphate groups may be employed for 
the generation of additional physical crosslinks in a chemically-crosslinked HA 
hydrogel network was conducted, since phosphate groups are the most common 
component of buffer salts, and have unique functions in mediating protein 
denaturation,(160) biomineralisation(161) and the stabilisation of HA-based 
electrospun fibres(162).  
Despite the crucial role of HA and phosphate groups in the ECM of biological 
tissues and hard tissue repair, only a few systematic studies have been reported 
concerning phosphate ion interaction with HA-based hydrogels, partially due to 
the limited control of respective molecular mechanisms and macroscopic 
effects.(163) Attempts to characterise the interaction between HA and the 
phosphate head group in phospholipid model membranes have been made 
through differential scanning calorimetry (DSC), fluorescence spectroscopy, 
small-angle X-ray scattering (SAXS), infrared spectroscopy (IR) and atomic force 
microscopy (AFM).(164) However, the resultant phosphate ion-HA interaction 
was too insignificant to be observed by the above mentioned methods. This 
underlines the experimental challenge in designing phosphate ion-mediated dual 
crosslinked HA-based hydrogel systems for the direct build up of bioinspired, 
mechanically competent HA matrices for hard tissue repair. 
Other than phosphate-HA interactions, the integration of hybrid 
micromorphologies has attracted great interest in bone regeneration, (165) and 
has been pursued in HA-based hydrogels aiming to realise bioinspired bone-like 
nanocomposites (147). The in situ precipitation of calcium phosphate was 
reported on the surface of HA hydrogels, yielding a calcium phosphate 
nanocomposite on the outer layer of the hydrogel scaffold.(146) Ion diffusion 
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methods have also been studied for mineralisation, including an electrophoresis 
approach (166) and a double-diffusion system (167). However, only amorphous 
hydroxyapatite (HAp) was observed in the electrophoresis approach, whereas 
only calcium phosphate minerals were obtained via the sophisticated double-
diffusion system. Consequently, accomplishing time-efficient and controllable 
formation of HAp crystals with native patterns and growing density is still a great 
challenge in the design of hierarchical 3-dimensional (3D) structures that mimick 
human bones.(168)  
In this chapter, two hyaluronic acid hydrogels that contained either cystamine or 
ethylenediamine covalent crosslinks were designed and assessed in a range of 
salts that partially comprise the Hofmeister series with the aim of developing a 
simple method to induce dual crosslinking and HAp mineralisation across the 
hydrogel structure. Hypothesis that non-toxic phosphate-binding sites could be 
introduced during the crosslinking reaction to further control the swellability and 
mechanical properties of the HA-based hydrogels and lay down the foundation of 
a new bioinspired HA-based dual crosslinked structure was set up and 
investigated in this chapter. Incubation of the hydrogels in aqueous solutions 
supplemented with hydrogen phosphate (HPO42-) generated hydrogen bonds 
acting as physical crosslinks, thereby yielding a very stable macrostructure with 
customisable mechanical properties. The mineralisation process of HPO42--
conditioned HA hydrogels was monitored in conventional simulated body fluid (c-
SBF), whereby unique hierarchical structure and gradients of hydroxyapatite 
mineral were recorded across the entire hydrogel network and confirmed by X-
ray computed microtomography (µCT). The simplicity and mildness of this dual 
crosslinking and mineralisation approach enables method transferability to other 
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biopolymers and offer great promise for the creation of bioinspired materials for 
cost-effective bone regenerative therapies. 
3.2 Materials and methods 
3.2.1 Materials 
HA sodium salt (molecular weight: 1,200 kDa, cosmetic grade) was purchased 
from Hollyberry Cosmetic, 4-(4,6-dimethoxy-1,3,5-triazin-2-yl)-4-methyl-
morpholinium chloride (DMTMM) and 2-(N-morpholino) ethanesulfonic acid 
(MES) were purchased from Fluorochem. (NH4)2SO4, Na2HPO4·7H2O, 
tris(hydroxymethyl)aminomethane (TRIS), cystamine dihydrochloride and 
ninhydrin reagent were purchased from Alfa Aesar. Na2SO4, CH3COONa, 
NaHCO3, KCl, K2HPO4·3H2O, MgCl2·6H2O, CaCl2, ethylenediamine was ordered 
from VWR. 2,4,6-trinitrobenzenesulfonic acid (TNBS), alamarBlueTM assay kit, 
CellTracker™ Green CMFDA Dye and LIVE/DEAD cell viability kit were 
purchased from ThermoFisher Scientific. All other reagents were purchased from 
Sigma-Aldrich. 
3.2.2 Hydrogel preparation 
HA hydrogels was fabricated in previous method as illustrated in Chapter 2.(169) 
Briefly, HA powder was dissolved in MES buffer (0.1 M) to obtain a weak acidic 
(pH=5.5) at room temperature in 2 wt.% concentration. DMTMM (2 equivalents 
per HA repeat unit) was then added at 37 °C to activate the carboxyl groups of 
HA. Keep the temperature at 37 °C for 1 hour, and a molar ratio of either 0.4 
moles of cystamine or ethylenediamine relative to the moles of each HA repeat 
unit was added to the solution. The stirring speed was increased to 1000 rpm for 
5 minutes and either 0.6 g or 0.8 g of the reacting solution was cast into 24-well 
plates. HA hydrogels were obtained after 2-hour incubation at 37 °C. Cystamine 
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crosslinked hyaluronic acid hydrogels were named as C2-40 and 
ethylenediamine crosslinked hydrogels were abbreviated as E2-40. 
3.2.3 TNBS assay to determine the extent of polymer crosslinking 
Polymer cross-linking density was investigated using the 2,4,6-trinitrobenzene 
sulfonic acid (TNBS) assay. 0.8 g of newly-synthesised hydrogel was freeze-dried 
without the washing step. Each dry network was immersed in 2 mL NaHCO3 
solution (4 wt.%) at 40 °C for 30 minutes to remove any unreacted cystamine or 
ethylenediamine. 1.0 mL of the supernatant was collected and measured by the 
TNBS assay. 1.0 mL TNBS solution (0.5 wt.% in deionised water) was added to 
the supernatant in the dark and incubated at 40 °C for 3 hours with a rotation 
speed of 120 rpm. 3 mL HCl (6 N) was added to the incubated solution and the 
temperature raised to 60 °C for 1 hour to terminate the reaction. After cooling to 
room temperature, the sample solutions were diluted with 5 mL of deionised 
water. The unreacted TNBS was washed out by extraction with 20 mL diethyl 
ether (×3). 5 mL of the retrieved sample solution was immersed in hot water to 
evaporate any diethyl ether and diluted with 15 mL of deionised water. Finally, 2 
mL of each solution was analysed by UV-Vis spectroscopy at 346 nm. 
Quantification of any cystamine or ethylenediamine residue was carried out by 
comparison with a cystamine or ethylenediamine calibration curve. 
3.2.4 Hydrogel swelling tests   
Various ion-hydrogel interactions were compared through changes in swelling 
ratios and network degradation. Each replicate of C2-40 and E2-40 hydrogels of 
known wet weight (ω0) was individually immersed in either (NH4)2SO4, Na2SO4, 
Na2HPO4·7H2O, CH3COONa, NaCl or deionised water (50 mL solution). Swelling 
tests in PBS buffer solution (LONZA) and conventional simulated body fluid (c-
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SBF) were also carried out. The wet weight was recorded at different time points 
(ωt) up to 4 weeks. All the single-salt solutions used were in 50 mM concentration 
and replaced by fresh solution every week with the same volume. The c-SBF 
solution was prepared as reported previously.(170) Briefly, all the salts were 
added to 960 mL deionised water in the following order: 8.036 g NaCl, 0.352 g 
NaHCO3, 0.225 g KCl, 0.230 g K2HPO4·3H2O, 0.311 g MgCl2·6H2O, 40 mL HCl 
(1.0 M), 0.293 g CaCl2, 0.072 g Na2SO4, 6.063 g TRIS. The pH of the solution 
was adjusted to pH 7.4 by adding HCl (1.0 M). 
The swelling ratio was calculated via bellowing Equation 3.1: 
𝑺𝒘𝒆𝒍𝒍𝒊𝒏𝒈 𝒓𝒂𝒕𝒊𝒐 (%) =
𝝎𝒕
𝝎𝟎
× 𝟏𝟎𝟎                                                      Equation 3.1 
3.2.5 Hydrogel compression tests 
Hydrogel compression properties were measured using Bose ELF 3200 
apparatus with a 0.02 mm/s compressive rate. All replicates were cut into 3 mm 
diameter cylinders. Compression stress and strain of either initial or salt-treated 
C2-40 and E2-40 hydrogels were evaluated and compared.  
3.2.6 Morphology study of the hydrogel network following salt treatment    
Hydrogel morphology was observed using a HITACHI 3400 scanning electron 
microscope (SEM) under 20 kV voltage with gold coating. All hydrogels were 
treated with different salts for 4 weeks and flushed with deionised water. SEM 
analysis was carried out on freeze-dried hydrogel networks. During the course of 
incubation, the hydrogel structures were also observed by optical microscopy 
(Zeiss) at different time points after various treatments. 
3.2.7 Mechanistic study  
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HPO42- interaction with the hydrogels formed was investigated via attenuated 
total reflectance Fourier transform infrared spectroscopy (ATR-FTIR, Bruker 
spectrometer) at room temperature and density functional theory (DFT) 
calculations. The optimized structures were obtained by DFT calculations at 
b3lyp/6-31G(d) level carried out using Gaussian 16 program.(171) The binding 
energy between the HA repeat unit and HPO42- was simply calculated as 
∆E=Etotal-(EHA+EHPO4), in which the single point energy was calculated at b3lyp/6-
311+G(d,p) level. For display, blue dashed lines indicated the hydrogen bonds, 
oxygen (O) atoms were depicted in red, nitrogen (N) in blue, sulfur (S) in yellow, 
carbon (C) in grey, hydrogen (H) in white and phosphorus (P) in pink. All the 
atoms which were involved in hydrogen bond formation are reported as spheres. 
3.2.8 Cell adhesion study during Na2HPO4 treatment of C2-40 hydrogels  
ATDC 5 chondrocytes (chondrogenic cell line) were used as non-mineralising 
joint resident cells of the bone-cartilage interface, which normally do not induce 
mineralization. Initial C2-40 network (0.6 g) was washed by sterile deionised 
water (×3) and basal cell culture medium (BM) (×3), which was composed of 50 
vol.% dulbecco’s modified eagle’s medium (DMEM, D6546) and 50 vol.% Ham’s 
nutrient mixture F12 (12-615), and supplemented by 5 vol.% fetal calf serum 
(FCS) and 1 vol.% penicillin and streptomicilin (PS). The final concentration of 
phosphorus in BM was 0.884 mM. Cells were labelled by Cell Tracker Green 
(CMFDA) and re-suspended in medium containing 2×105 cells/mL. 100 μL cell 
suspension (2×104 cells) was injected on the surface of each hydrogel (n=3). 2 
mL of BM was added into each well after 3 hours seeding. Cell attachment and 
growth was observed and recorded after 48 hours.  
To study the influence of Na2HPO4 on cell migration, BM was replaced by 
Na2HPO4 treated medium (TM) after 1-week of culture. TM was prepared from 
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the basal medium, supplemented by sterile Na2HPO4·7H2O powder to achieve a 
final concentration of 1.884 mM (1 mM increase in phosphate, compared with 
BM). In the control group, the medium was replaced by fresh BM.  
Cell attachment and growth were investigated by fluorescence/optical 
microscope (Zeiss), cell migration was studied via Laser scanning confocal 
microscopy (LEICA TCS SP8, excitation wavelength 488 nm). All the samples 
were washed by sterile PBS (×3) to remove any dead cells and impurities before 
calcein-AM staining. 
3.2.9 Acellular mineralisation  
After 4-week immersion in Na2HPO4 solution (50 mM, 1.0 L, 37 °C), C2-40 
hydrogels (n=3) were transferred into deionised water for 24 hours to remove any 
free phosphate salt, then soaked in 200 mL calcium chloride (10 mM) for another 
24 hours.(172) Calcium-treated C2-40 samples were flushed by deionized water 
to remove any surface salt and subsequently soaked in 1.0 L c-SBF for 2 weeks 
at 37 °C for mineralisation. The entire process was presented in Figure 3.2. Non-
Na2HPO4 treated C2-40 samples were immersed in CaCl2 (10 mM, 200 mL) for 
24 hours and underwent the same mineralisation operation as a control group. 
The mineral structure was confirmed by X-Ray powder diffraction (XRD) at room 
temperature from 20°-60°. Freeze-dried initial and mineralised C2-40 networks 
and mineralised C2-40 networks after being burnt at 1000 °C for 30 minutes were 
measured. The 3D structure of mineralisation was investigated by X-ray 
computed microtomography (µCT) (Skyscan 1072, Bruker, Kontich, Belgium). 
Samples were scanned at 100 kVp, 100 mA, and 11.19 μm pixels, with a 1-mm 
aluminium plus copper filter and a scanning time of around 60 minutes. A 
reconstruction software program (NRecon; SkyScan) was used to convert the 
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raw data into bitmap (bmp) files. 3D alignment and registration of samples were 
done using Data Viewer software (v1.4.3; Bruker microCT). Both CTan and CTvol 
(v1.10.11.0; Bruker microCT) software were used for the 3D structural analysis. 
  
Figure 3.2 Illustration of mineralisation process.  
3.2.10 Statistical analysis 
For statistical analysis, all the results were analysed with at least three replicates 
(n≥3). The results are presented as Mean±SD. The significant difference was 
calculated through One way ANOVA analysis with a p-value at 0.05, which was 
considered as significant. These were labelled as *p ≤ 0.05, **p ≤ 0.01, ***p ≤ 
0.001, ****p ≤ 0.0001.  
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3.3 Results and discussion  
3.3.1 Hydrogel crosslinker density 
Two hydrogels were formed, denoted as C2-40 and E2-40, whereby C and E 
signify HA crosslinking with either cystamine or ethylenediamine, respectively; 2 
is the wt.% concentration of HA in the hydrogel-forming solution, whilst 40 is the 
mol.% of each crosslinker, with respect to HA’s carboxylic groups, added during 
the HA crosslinking reaction. The density of reacted crosslinkers was evaluated 
by TNBS assay and calculated through ethylenediamine calibration equation: 
y=0.0658x-0.0246, R2=0.9743, y=absorbance, x=ethylenediamine concentration 
(mM) as presented in Figure 3.3 or cystamine calibration equation: y=0.0666x-
0.0184, R2=0.9933, y=absorbance, x= cystamine concentration (mM) as 
evaluated in chapter 2.(169) When adding 40 mol.% of either cystamine or 
ethylenediamine, approximately 25 mol.% of crosslinker reacted with HA during 
gel formation (Table 3.1), ensuring that a comparable crosslink density was 
expected for both hydrogel networks. 









C2-40 2.0 40.0 25.30±0.85 
E2-40 2.0 40.0 25.27±0.01 
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Figure 3.3 TNBS calibration curve of ethylenediamine. 
3.3.2 Swelling behaviour of HA hydrogels in salt-supplemented aqueous 
solutions  
Hydrogel swelling equilibrium was reached after 1 day for both C2-40 and E2-40 
hydrogels immersed in various solutions (Figure 3.4 a&b). The swelling ratio (SR) 
of C2-40 samples was found to be in the region of 150 wt.% in all salt solutions, 
in contrast to a swelling ratio of 425 wt.% in deionised water. The interaction of 
selected salts with C2-40, which results in decreased hydrogel swelling, followed 
the order Na2HPO4 ˃ (NH4)2SO4 = Na2SO4 ˃ NaCl ˃ CH3COONa. For E2-40, 
lower swelling ratio values (~325 wt.%) were observed in water, compared with 
hydrogel C2-40, which suggested that cystamine and ethylenediamine had 
different influence on hydrogel swelling. Anion-HA hydrogel interactions were 
obvious in the 4-week swelling study and followed the order Na2SO4 ≥ (NH4)2SO4 
˃ NaCl ˃ CH3COONa ˃ Na2HPO4. When comparing the two hydrogels in salt 
solutions, the most striking difference is the swelling behaviour in Na2HPO4-
supplemented solutions. Following incubation of C2-40 in Na2HPO4, a significant 
decrease in the SR was observed from 123±2 wt.% (1 day) to 62±1 wt.% (28 
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days). In contrast, the SR of E2-40 in Na2HPO4 increased from 140±5 wt.% (1 
day) to 161±4 wt.% (28 days). This observation was hypothesised to reflect the 
specific hydrogen bond interaction between HPO42- and cystamine-crosslinked 
HA chains. 
 
Figure 3.4 Swelling ratio of C2-40 (a) and E2-40 (b) hydrogels in (NH4)2SO4, 
Na2SO4, Na2HPO4, CH3COONa, NaCl and deionised water (H2O). Insert 
graphs: Time (d) in X-axis and Swelling ratio (%) in Y-axis. All the salt 
solutions used were in 50 mM concentration and replaced by fresh solution 
every week with the same volume, the H2O group was replaced by 50 mL 
deionised water every week.   
As observed in the Na2HPO4-supplemented solution, the swelling ratio of 
samples C2-40 in PBS solution presented a similar decreasing trend over time 
(SR: 101±3 wt.% (1 day) → 76±2 wt.% (28 days)) (Figure 3.5), supporting the 
hypothesis that phosphate ions reduce hydrogel swelling. However, the swelling 
ratio of ethylenediamine crosslinked hydrogel (E2-40) was stable (~120%) for the 
first 7 days before marginally decreasing over the next 21 days (SR: 119±1 wt.% 
(7 days) → 114±2 wt.% (28 days)) (Figure 3.5). Based on the significant decrease 
in SR measured in hydrogel C2-40 following incubation in both Na2HPO4 and 
PBS solution, the swelling ratio was also recorded in conventional simulated body 
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fluid (c-SBF) to further elucidate any HPO42--mediated interaction with cystamine-
crosslinked HA.  
 
Figure 3.5 Swelling ratio of C2-40 and E2-40 hydrogels in PBS and C2-40 in c-
SBF. 
As expected, a similar but slower decrease in hydrogel swelling was recorded in 
c-SBF over time, which is likely due to the different phosphate concentration 
across the selected solutions (Table 3.2). The significant difference in swelling 
ratio of hydrogel C2-40 was therefore attributed to the interactions between 
HPO42- ions and cystamine-crosslinked hyaluronic acid, offering a new dimension 
for adjusting the swelling of the hydrogel by altering the chemical composition of 
the crosslinker. 
Table 3.2 The swelling clarification of C2-40 hydrogels in phosphate-




Swelling Ratio (%) 
Mean±SD 
Na2HPO4 50 61.69±0.66 
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PBS 6.658 76.44±2.00 
c-SBF 1.001 86.93±1.26 
*Concentration of hydrogen phosphate and dihydrogen phosphate. 
3.3.3 Compressive properties of salt-treated hydrogels  
Both C2-40 and E2-40 hydrogels were reinforced by ions to some degree, 
whereby stiffer networks and varying compression strain and stress at break were 
measured as presented in Figure 3.6 and Figure 3.7, which further proved the 
effect of salts on hydrogel mechanical properties.  
Among the salt-treated samples, the most interesting phenomenon was observed 
in C2-40 hydrogels in Na2HPO4 environment, whereby the lowest value of 
compression strain at break was recorded after 1 day (77±0.3%) before 
decreasing to 54±1.5% after 4 weeks treatment. All the other groups formed a 
relatively stable network (Figure 3.6, b and d). This observation further supported 
the development of selective, strong HPO42--mediated physical crosslinks in the 
C2-40 hydrogel following salt treatment, so that the mechanical behaviour of 
resulting dual crosslinked hydrogel network could be adjusted from elastic to stiff. 
This variation in mechanical behaviour was also supported by the trends of 
compression stress at break measured in Na2HPO4-treated and water-incubated 
groups after 1 day and 4 weeks (Figure 3.6, a and c). However, in E2-40 hydrogel 
groups, no elastic-stiff change was observed in all testing salts solution after 1 
day and 4 weeks (Figure 3.7).  
The additional interactions between HPO42- groups and the cystamine-
crosslinked HA network were therefore investigated as a means to induce 
acellular biomineralisation of cystamine crosslinked HA hydrogel, aiming to 
develop a cell-friendly design of bioinspired bone-like composites.  
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Figure 3.6 Compression measurement of original hydrogel C2-40 and after being 
immersed in different salt solution, compression stress at break after 1 day (a) 
and 4 weeks (c), compression strain at break after 1 day (b) and 4 weeks (d). All 
the statistical analysis was presented after comparison with H2O group. 
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Figure 3.7 Compression measurement of original hydrogel E2-40 and after being 
immersed in different salt solutions, compression stress at break after 1 day 
(a) and 4 weeks (c), compression strain at break after 1 day (b) and 4 weeks 
(d). All the statistical analysis was presented after comparison with H2O 
group. 
3.3.4 Salt-induced morphology change of HA hydrogels  
The surface morphology of freeze-dried hydrogels was investigated by SEM after 
4-week immersion in Na2HPO4-supplemented solution. Distinguished surface 
morphology changes were observed in all testing groups, compare with H2O 
control group. Crystal-like salts were not observed by SEM in both hydrogel 
samples (C2-40 in Figure 3.8 and E2-40 in Figure 3.9), suggesting that salts 
diffused into the hydrogel structure and attached to the network, in agreement 
with the salt-enhanced compression properties and decreased swelling ratio.  
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The interesting phenomenon was also shown in the different morphologies 
between C2-40 and E2-40 after treating by a same salt. For example, in Na2SO4 
group. The aligned porous structure of C2-40 surfaces (Figure 3.8b), however, 
did not appear in E2-40 samples (Figure 3.9b). Similar change was also observed 
in Na2HPO4 group, that Na2HPO4 stack with C2-40 network (Figure 3.8c), 
however, formed porous structure with E2-40 (Figure 3.9c). which further 
supported the hypothesis that HPO4- has a targetable function to cystamine 
crosslinked hyaluronic acid hydrogels.  
 
Figure 3.8 SEM images of freeze dried C2-40 hydrogels after being immersed in 
related solution for 4 weeks. (NH4)2SO4 (a), Na2SO4 (b), Na2HPO4 (c), 
CH3COONa (d), NaCl (e), PBS (f), H2O (g). 
 
Figure 3.9 SEM images of freeze dried E2-40 hydrogels after being immersed in 
related solution for 4 weeks. (NH4)2SO4 (a), Na2SO4 (b), Na2HPO4 (c), 
CH3COONa (d), NaCl (e), PBS (f), H2O (g). 
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To further elucidate the extent of the above-mentioned ion interactions in 
morphological change, hydrogels were incubated in the presence of Na2HPO4 
(50 mM), PBS solution and c-SBF for up to three months. Initial HA hydrogels 
were highly transparent that could not be observed by optical microscopy. 
However, visible aggregation of the hydrogel surface was observed surprisingly 
after incubated in HPO42--contained buffer (Figure 3.10), whereby parallel “Z” 
shape aggregates conjugated with each other in 7-10 µm gaps after Na2HPO4 
treatment, in addition to lightly conjugated parallel channels with 10-13 µm gaps 
(Figure 3.10a). Although Z-shaped channels were observed to be more linear in 
c-SBF (Figure 3.10c), no visible aggregation was seen in hydrogels incubated for 
three weeks in either deionised water or other HPO42-  free salt solutions. These 
results suggest the development of strong interactions between hydrogel C2-40 
and HPO42- ions as the mechanism behind microscale aggregation on the 
hydrogel surface. On the other hand, when the incubation time in PBS solution 
was extended from 3 weeks to 3 months, regular “Z” shapes with 20-30 µm gaps 
were clearly visible in C2-40 hydrogels (Figure 3.10 d&e). This result is attributed 
to the slow HPO42- interaction in PBS solution with respect to c-SBF, due to the 
decreased concentration of phosphate ions (Table 3.2). Deep microscale 
aggregation, rather than surface conjugation, was observed as highlighted by the 
red arrows. This aggregation mechanism provided the opportunity for creating 
reinforced dual crosslinked hydrogel networks with adjustable morphologies in 
near-physiological conditions (as indicated by previous compression tests, Figure 
3.6 b&d) and an easy and stable method to build up HPO42- sites in the hydrogel 
for subsequent acellular biomineralisation. 
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Figure 3.10 Optical images of C2-40 aggregation after being immersed in 
Na2HPO4 (a), PBS (b), c-SBF (c) for 3 weeks, and C2-40 hydrogels after in 
PBS buffer for 3 months. Aggregation at deeper network was indicated with 
red arrows.  
3.3.5 Mechanism study of HPO42- stabilisation   
The development of physical crosslinks between HPO42- and cystamine-
crosslinked hyaluronic acid was further supported by quantum chemistry 
calculations. Three models of cystamine-crosslinked hyaluronic acid (C-HA) 
repeat unit were optimised according to their energy minimum configuration 
(Figure 3.11 a&b). The most stable structure was achieved with the lowest total 
interaction energy (∆EC-HA3=-170.751 kcal/mol) in model C-HA3, where 3 atoms 
of oxygen (O) in the HPO42- species form hydrogen bonds with the NH (1, 5) and 
OH (2, 3) groups of crosslinked HA, whilst the OH group in HPO42- forms 
hydrogen bonds with the O atom of HA (4). On the other hand, increased total 
interaction energy were measured with the other two models (∆EC-HA1=-162.075 
kcal/mol, ∆EC-HA2=-169.501 kcal/mol), as presented in Figure 3.11.  
To investigate the influence of both the disulfide bridge and the number of carbon 
atoms in the crosslinking chain, the same binding sites as in C-HA were 
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calculated in HA structure models crosslinked with either 1,6- hexane diamine (6 
carbon atoms), butane-1,4-diamine (4 carbon atoms) or ethylenediamine (2 
carbon atoms), and abbreviated as H-HA, B-HA, E-HA, respectively (Figure 
3.11a).  
In the H-HA models, the strongest interaction was obtained in model H-HA3 with 
a ∆EH-HA3=-162.149 kcal/mol (Figure 3.11 and Table 3.3), which was 8.602 
kcal/mol higher than the one recorded in model C-HA3 (∆EC-HA3=-170.751 
kcal/mol). Although no direct binding contribution of the S-S bridge was observed, 
the optimised structure and the reduced binding energy proved an indirect effect. 
In B-HA models, ∆EB-HA3=-167.491 kcal/mol was calculated in the most stable 
configuration, hinting at a lower interaction compared to the 1,6-hexanediamine-
crosslinked HA model. Since butane-1,4-diamine is two carbon atoms shorter 
than 1,6-hexanediamine, the lower interaction measured in model B-HA3 with 
respect to H-HA3 suggests that the crosslinker length affects the development of 
HPO42--mediated physical crosslinks in the hyaluronic acid crosslinked chain. 
This observation is supported by the energy calculations in model E-HA, 
describing HA chains crosslinked with ethylenediamine as the shortest 
crosslinker of the three. Only one stabilised structure was obtained with this 
system, with a final ∆EE-HA=-155.330 kcal/mol, corresponding to the lowest 
interaction of all optimised models. Nevertheless, the lack of a stable 
configuration in the other two models of E-HA is against the development of 
HPO42--mediated hydrogen bonds in ethylene diamine-crosslinked HA, thereby 
supporting the role of the crosslinker length in the development of phosphate ion-
HA secondary structures.  
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Figure 3.11 Hydrogen phosphate interactions optimised through DFT 
calculations. Molecular structure of computed crosslinkers (a). Hydrogen 
bond interaction calculations between HPO42- and crosslinked hyaluronic 
acid repeat unit, crosslinked by cystamine (C-HA), 1,6-hexanediamine (H-
HA), butane-1,4-diamine (B-HA) or ethylenediamine (E-HA). The optimised 
models with lowest interaction energy in each group were in red squares.  
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Table 3.3 Optimised computing results of interaction energy in different models. 











Experimentally, a band corresponding to a P=O vibration was observed in the IR 
spectrum after Na2HPO4 treatment, with new peaks at 1230 cm-1 and 1202 cm-1 
present in both C2-40 and E2-40 samples, which were initially shown as 1261 
cm-1 and 1185 cm-1 in Na2HPO4 (Figure 3.12a). C2-40 and E2-40 hydrogels were 
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washed with deionised water for 24 hours to remove any free Na2HPO4 residue 
and freeze-dried prior to IR measurement. The existence of a shifted peak related 
to the P=O vibration provided strong evidence for hydrogen phosphate interaction 
between P=O and cystamine crosslinked hyaluronic acid units. The most 
interesting phenomenon was the obvious shift to almost disappearance of the 
original 1700 cm-1 peak (Figure 3.12b) in the IR spectrum of Na2HPO4-treated 
sample C2-40, which is attributed to the amide linkage of HA (position 5 of model 
C-HA3, Figure 3.11) and which is still clearly visible in the IR spectrum of sample 
E2-40 following the same salt treatment. The proposed hydrogen bond between 
the HPO42- ion and the nitrogen atom (N) of the amide bond (position 5 of model 
C-HA3, Figure 3.11) (169) may shift this peak to 1640 cm-1. This result strongly 
supports the mechanism of multiple hydrogen bonds in cystamine-crosslinked HA 
chains.  
As the most stable interaction was obtained when the phosphate-amide site 
binding was considered, in agreement with Barrett’s work on hyaluronic acid 
solutions,(156) this research proposed that minimising steric hindrance by 
adjusting the length of the crosslinker is critical to providing proper access to 
HPO42- ions and enabling coordination and physical crosslinking with amide 
bonds. Furthermore, the introduction of disulfide bridges in the HA network 
provided HA crosslinked chains with increased flexibility and increased 
opportunities for developing secondary interactions with phosphate groups.(173) 
This potential intermolecular interaction may induce rearrangengement of the 
disulfide bonds and hydrophilic-hydrophobic sites, so that detectable effects 
could be observed at the macroscale and on respective material properties as 
shown in results.  
 




Figure 3.12 (a) IR spectrum of Na2HPO4 (top), Na2HPO4 treated C2-40 network 
(middle) and E2-40 network (bottom) for 4 weeks. (b) IR spectrum of initial 
C2-40 and E2-40 networks without salt treatment. 
3.3.6 ATDC 5 cell adhesion study with C2-40 hydrogels during HPO42- 
treatment 
Following the results obtained in acellular conditions, a biocompatibility study was 
carried out with ATDC 5 chondrocytes. Chondrocytes were selected as non-
mineralising joint-resident cells, aiming to investigate both the material-induced 
cell response and any cell culture-induced effect on the material morphology. 
After 2-day cell culture, some aggregated HA network was already observed on 
the surface of freshly-synthesised hydrogel C2-40 (Figure 3.13a), in line with the 
presence of phosphate groups in the cell culture medium (0.844 mM in BM). The 
aggregation kinetics were accelerated with respect to previously discussed 
acellular conditions, an observation which can be explained by considering the 
multiple ingredients in cell culture medium and cell metabolism. At the cellular 
level, the fluorescent-labelled live cells aligning along the aggregated structure 
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are visible (Figure 3.13b), whereby the weak fluorescence is likely due to the 
quenching of the cell-labelling dye following cell growth.  
 
Figure 3.13 Cell Tracker Green labelled ATDC 5 cells on C2-40 surface after 2-
day culture in BM, optical image (a) and fluorescent image (b). 
After 1-week cell attachment and migration in BM, the conditional cell culture was 
started with replaced fresh TM (1.884 mM phosphate), control group was 
replaced by BM (0.884 mM phosphate). The cell culture time was then recounted 
as “conditional cell culture time”. After another 3 days of cell culture and calcein-
AM staining, few fluorescent cells were observed via 3D confocal microscopy in 
either BM group (a) or TM group (b) (Figure 3.14). To confirm this, C2-40 
hydrogels without cells were set as a blank control, whereby only one fluorescent 
dot with a maximum length of 10 µm was observed in the confocal image (Figure 
3.15). This observation is unlikely to be related to living cells and is mostly 
attributed to impurity or fluorescence from HPO42- aggregation, as the cells 
observed in the hydrogels were approximately 30 µm in length and 10 µm in width 
(Figure 3.14).  
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Figure 3.14 After 3-day conditional culture, live ATDC 5 cells were stained via 
calcein AM and observed by fluorescence microscope, cell migration was 
investigated by laser confocal microscope. BM (a) and (c), TM (b) and (d). 
 
Figure 3.15 After 3-day conditional culture, laser confocal image of blank control 
C2-40 gel in TM group. 
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When ATDC 5 cells were independently seeded on the surface of each initial C2-
40 hydrogel in both BM and TM, most of the cells were found to adhere to the 
TCPs (Figure 3.16). Few dead cells were captured, regardless in BM or TM 
groups. The slightly weaker Live staining (green) in TM group, should be caused 
by the high cell density, which meant that the Na2HPO4 treatment was non-toxic 
during a 3-week conditional cell culture period and could increase ATDC 5 cells 
proliferation at some degree (Figure 3.16) after comparing with BM groups.  
 
Figure 3.16 ATDC 5 cells growth after 3-week conditional culture on TCPs. Cells 
were cultured in either BM (a-c) or TM (d-f). Cells were stained via Live 
(Green) & Dead (Red) marker and observed by optical/fluorescence 
microscope.  
These results demonstrate that the salt-induced hydrogel aggregation process 
provides a regular channel for cell attachment and growth on the HA hydrogel 
surface as expected (Figure 3.17). The cell-free formation of previously described 
salt-mediated microstructures (Figure 3.10) can be proposed as the first stage of 
the hydrogel biomineralisation process. Although HA hydrogels were known for 
3D cell culture as scaffolds, however, no obvious ATDC 5 cells were aggregated 
in C2-40 hydrogels no matter in BM or TM groups (Figure 3.17).  
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Here, the absence of cells is key to minimising the risk of cell aggregation on the 
hydrogel surface as the first step for mineralisation, which could otherwise induce 
steric effects, cause local tissue inflammation and delay HAp crystallisation for 
bone regeneration in hydrogel networks. 
 
Figure 3.17 ATDC 5 cells growth after 3-week conditional culture on C2-40 
hydrogels. Cells were cultured in either BM (a-c) or TM (d-f). Cells were 
stained via Live (Green) & Dead (Red) marker and observed by 
optical/fluorescence microscope. 
3.3.7 HAp growth characterisation within HPO42--treated HA-based 
hydrogels 
Both Na2HPO4 and non-Na2HPO4-treated C2-40 replicates were transferred into 
deionised water for 24 hours to remove any free salt, and then further treated with 
200 mL CaCl2 (10 mM) for 24 hours. The calcium concentration was chosen from 
a study on milk as one of the main sources for calcium supplementation.(172) All 
the samples were flushed with deionised water before the mineralisation process, 
which was subsequently carried out in c-SBF (1.0 L) at 37 °C for 2 weeks. 
Remarkably, a homogeneous HAp phase formed in the C2-40 hyaluronic acid 
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network (Figure 3.18a, left), with full mineralisation observed across the whole 
hydrogel structure (Figure 3.19). No visible mineral was observed in the control 
group without HPO42- treatment, ensuring that the hydrogel surface remained 
transparent (Figure 3.18a, right). To further characterise the mineralised structure 
of Na2HPO4-conditioned hydrogel, XRD analysis was carried out (Figure 3.18b). 
A clear stacking structure corresponding to HAp was observed after heating the 
sample at 1000 °C for 30 minutes. Some diffraction was recorded for the freeze-
dried network at 2θ = 27°, 33° and 35°, again corresponding to the HAp 
phase,(174) whilst no peak was observed in the initial freeze-dried C2-40 
hydrogel network.  
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Figure 3.18 Optical images of wet mineralised C2-40 hydrogels and non-
mineralised C2-40 control after HPO42- treatment (a). XRD results of 
mineralised C2-40 (b), after 1000 °C burning (top), freeze-dried mineralised 
network (middle), initial freeze-dried C2-40 network (bottom). 3D 
reconstruction of mineralised C2-40 after µCT scanning (c), Length-Height 
direction (top), Height-Width direction (bottom). The presented images were 
minerals inside C2-40 at wet status, HA network of C2-40 was invisible in 
µCT scanning.  
 
Figure 3.19 Optical images of the wet mineralised sample C2-40 after HPO42- 
treatment (side view, left) and C2-40 control (top surface, right). 
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In addition to XRD spectra and digital macrographs, µCT was carried out as a 
non-damaging technique to visualise the 3D macrostructure of the mineralised 
C2-40 composite obtained following 2-week incubation in c-SBF (Figure 
3.18).The cross-sectional image in Figure 3.20 clearly reveals the gradient 
decreasing HAp density along with Z-axis direction, in agreement with the results 
obtained from the µCT 3D reconstructed models (Figure 3.18 c and d). Mineral 
growth with remarkable growing density was successfully achieved after 
Na2HPO4 hydrogel treatment, rather than ion distribution surrounding the gel 
surface or limited formation of mineral particles.(146) (166) This result 
demonstrates the high potential of the HAp-mineralised C2-40 hydrogel as a 
scaffold for hard tissue repair, particularly as gradient hydrogels for tissue 
regeneration.(175) 
 
Figure 3.20 Macro-pattern study of mineralised C2-40 from μCT scan, combined 
3-dimension image (a), cross section of each axis (b). 
3.4 Conclusion  
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The effect of the inclusion of a range of salts within cystamine and 
ethylenediamine-crosslinked HA-based hydrogels was investigated as an 
acellular route to realise dual crosslinked bioinspired bone-like nanocomposites. 
Specific and strong hydrogen bond interactions acting as physical crosslinks 
were first discovered between cystamine-crosslinked HA chains and HPO42- 
groups, as indicated by the decreased swelling and decreased compression at 
break, IR spectroscopy and DFT calculations. The introduction of phosphorus 
nuclei was key to enable this interaction, which was successfully leveraged to 
accomplish HAp growth across the hydrogel structure. Gradient HAp was 
obtained and visualised by μCT 3D reconstruction after hydrogel incubation in 
1.0 L conventional simulated body fluid for 2 weeks. A novel acellular method to 
generate 3-dimensionally dual crosslinked and mineralised structures is 
developed that has great appeal for hard tissue repair. 
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Chapter 4  
The Facile and Additive-Free Synthesis of a cell-friendly 
Iron(III)-Glutathione Complex  
▪ This chapter has been published. Reference [Gao, Z., Carames-mendez, 
P., Xia, D., Pask, C.M., Mcgowan, P.C., Bingham, P.A., Scrimshire, A., 
Tronci, G. and Thornton, P.D. 2020. The facile and additive-free synthesis 
of a cell-friendly iron(III)–glutathione complex. Dalton Transactions. 49, pp. 
10574-10579.] 
The straightforward creation of an unreported glutathione-stabilised iron(III) 
complex is reported. In contrast to previous reports, glutathione was shown to 
coordinate and stabilise iron directly under physiological conditions in the 
absence of additional sulfur containing molecules, such as sodium sulfide. The 
complex was extensively characterised; the molecular geometry was determined 
as two inequivalent octahedra, approximately 2/3 of which is slightly distorted 
towards more tetrahedral in character, with the remaining 1/3 more regularly 
octahedral. The dispersion of the iron(III)-glutathione complex in aqueous 
solution yielded particles of 255±4 nm in diameter that enhanced the growth and 
proliferation of L929 fibroblast cells over 7 days, and inhibited the activity of matrix 
metalloproteinase-13. Consequently, the unprecedented glutathione-stabilised 
iron(III) complex disclosed has potential use as a simple-to-prepare growth factor 
for inclusion within cell culture media, and is an excellent candidate as a 
therapeutic for the treatment of metalloproteinase-13-associated diseases. 
Illustrated in Figure 4.1. 
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Figure 4.1 Illustration of Iron(III)-Glutathione formation and functions.  
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4.1 Introduction 
GSH, (structure was presented in Figure 2.2 in page 33) is imperative for cellular 
defence against reactive oxygen species that cause apoptosis and tissue 
inflammation.(176) Free radicals and reactive oxygen species are deactivated by 
the sulfhydryl moiety that the tripeptide presents, undergoing conversion to stable 
and innocuous compounds. Numerous disease states are linked to GSH 
deficiency in cells, including chronic hypertension,(177) pulmonary fibrosis,(178) 
human immunodeficiency virus-related disease,(179) and respiratory distress 
syndrome.(180) GSH is administered as an oral supplement, however the half-
life of GSH within the blood plasma (t = 1.6 min) ensures that a significant 
proportion of the supplement is oxidized prior to reaching the gastrointestinal 
tract.(181) Consequently, alternative cell-friendly methods of GSH storage and 
localized delivery, or reversible GSH modification, are required to elevate 
depleted tissue GSH levels. 
Transition metal ions perform a number of cellular functions within eukaryotes, 
including photosynthesis and respiration.(182) Metalloproteins, which contain a 
metal ion cofactor, play a vital role in the storage and transport of enzymes and 
signal transduction proteins, and make-up a third of proteins within the human 
body.(183) Iron is the most abundant redox-active metal within the body owing to 
its presence within haemoglobin. The natural presence of haemoglobin in vivo 
provides great encouragement for the formation of iron-protein and iron-peptide 
complexes as materials that are suitable to be deployed within living organisms. 
Complexes that contain redox-active metal centres may be exploited as 
therapeutics and diagnostic tools.(184) Notably, such organometallic materials 
have been proposed as contrast agents in which the variety of oxidation states 
that the redox-active metal can adopt is associated with distinct paramagnetic 
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properties that enable their effective detection in vivo.(185) Iron has potential for 
use within a contrast agent composition due to its capability to form high-spin 
Fe3+ complexes. Wang et al. recently reported biochemically responsive Fe2+-
PyC3A complexes that, upon oxidation by reactive oxygen species, form Fe3+-
PyC3A that enable contrast enhancement within inflamed pancreatic tissue.(186) 
Within healthy tissue, Fe2+-PyC3A is maintained and so signal enhancement 
does not occur. 
GSH has been reported to form stable complexes with transition metals including 
mercury,(187) silver,(188) cadmium,(189) and zinc.(190) Consequently, it has 
been cited as a candidate for metal speciation in aqueous environments for the 
detection and remedy of heavy metal pollution.(191) However, the formation of 
hydrolytically-stable iron-GSH complexes is more limited, especially in a cluster-
free configuration. Qi et al. reported that glutathione-complexed clusters [2Fe-2S] 
are stabilised by glutathione aggregates that form intermolecular salt bridges and 
hydrogen bonds, providing a stable binding pocket for the [2Fe-2S] cluster 
core.(192-193) However, despite these advances, the binding of glutathione to 
ferrous iron in the absence of iron-sulfur cluster formation has not been reported 
due to the rapid reduction of Fe3+ in the presence of GSH.(194-195) In this case, 
a complex that contains GSH ligands, but lacks [Fe2S2] bridged dimers, is 
anticipated to form. 
This chapter reports the formation of a Fe3+-GSH complex by combining 
equimolar quantities of GSH and FeCl3. Additives that promote iron-sulfur cluster 
formation, for instance sodium sulfide, were not included in the synthesis. 
Analysis reveals that reduced GSH forms a complex with Fe3+, yielding a stable 
complex suitable for extensive characterisation. Notably, the Fe3+-GSH complex 
possessed excellent cell compatibility, promoting the growth and proliferation of 
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L929 fibroblast cells over seven days in vitro. Consequently, it is highly promising 
as a drug-free approach to enhance fibroblast growth in vitro within cell culture 
medium at low concentrations (< 0.5 mg/mL), and as a constituent to restore 
homeostasis in chronic tissue states.   
4.2 Materials and methods 
4.2.1 Materials 
Iron(III) chloride hexahydrate and Iron(II) chloride tetrahydrate were purchased 
from Sigma-Aldrich, L-glutathione (reduced) was purchased from Alfa Aesar, L-
glutathione oxidised (GSSG) was purchased from BioSci. alamarBlueTM Assay 
kit was purchased from ThermoFisher Scientific. 
4.2.2 Fe3+-GSH complex preparation 
123 mg (0.4 millimoles) of GSH was added to 4 mL FeCl3 solution (0.1 M), and 
the mixture was mildly agitated by vortex mixing for 2 min. Then, the complex 
was precipitated in 40 mL ethanol. The products were collected by centrifugation 
at 10,000 rpm for 15 min. The Fe3+-GSH complex produced was washed three 
times with ethanol and dried at 37 °C.  
To determine the effect that GSH in its oxidised form (GSSG) has on the oxidation 
state of Fe, and if it can act as a chelating agent with Fe, 123 mg (0.2 millimoles) 
of GSSG were added to 4 mL FeCl2 solution (0.1 M). Agitation in ethanol, and 
product precipitation, collection and drying were performed similar to the previous 
complex formation with GSH. 
4.2.3 Fe3+-GSH complex structure analysis 
The coordination between Fe3+ and GSH was confirmed by UV-Vis spectroscopy. 
Various amounts of GSH solution (0.1 M) were independently added to 600 μL 
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FeCl3 (0.1 M) at different molar ratios. Deionised water was then added to dilute 
the complex solution to a final concentration of 40 mM FeCl3. Absorbance was 
measured with baseline correction at 690 nm, at which point no components of 
the solution absorb significantly. Nine different molar ratios of Fe:GSH between 
6:1 and 1:1.5 were assessed.  
The structure of the Fe3+-GSH complex was assessed by fluorescence 
spectroscopy (FS). 1.0 mg/mL Fe3+-GSH suspension was prepared via ultrasonic 
agitation for 10 min to achieve a homogeneous H2O dispersion. 2 mL of each 
dispersion was used for FS analysis at room temperature, using an excitation 
wavelength of 408 nm. The blank and control spectra were carried out using 0.1 
M FeCl3, 0.1 M GSH and a FeCl3-GSH mixture (1.2:1, 1:1 and 1:1.2 molar ratio) 
with consistent FeCl3 concentration.  
57Fe Mössbauer spectroscopy was applied to confirm the Fe3+-GSH configuration 
and iron valence. Measurements were carried out using acrylic absorber discs 
(area 1.767 cm2) loaded with sample to achieve a Mössbauer thickness of 1. The 
14.4 keV γ-rays were supplied by the cascade decay of 25 mCi 57Co in Rh matrix 
source, oscillated at constant acceleration by a SeeCo W304 drive unit, detected 
using a SeeCo 45431 Kr proportional counter operating with 1.745 kV bias 
voltage applied to the cathode. All measurements were carried out at room 
temperature over a velocity range of ±4 mm s−1, and were calibrated relative to 
α-Fe foil. Spectral data were fitted using the Recoil software package, using 
Lorentzian line shapes. Proton nuclear magnetic resonance spectroscopy (1H 
NMR, Bruker AV400, 400 MHz) was carried out on Fe3+-GSH solution (D2O) to 
investigate the coordination between Fe and GSH. For further structural 
information, attenuated total reflectance Fourier transform infrared (ATR-FTIR, 
Bruker) spectroscopy was used to analyse dried Fe3+-GSH powder between 400-
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4000 cm-1. Circular dichroism (CD) spectroscopy was applied to investigate the 
chirality change from GSH to Fe3+-GSH complex. CD spectra was carried with a 
bandwidth of 2.0 nm between 250-750 nm. 
Proton nuclear magnetic resonance spectroscopy (1H NMR, Bruker AV400, 400 
MHz) was carried out on Fe3+-GSH solution (D2O) to investigate the coordination 
between Fe and GSH. For further structural information, attenuated total 
reflectance Fourier transform infrared (ATR-FTIR, Bruker) spectroscopy was 
used to analyse dried Fe3+-GSH powder between 400-4000 cm-1. Circular 
dichroism (CD) spectroscopy was applied to investigate the chirality change from 
GSH to Fe3+-GSH complex. CD spectra was carried with a bandwidth of 2.0 nm 
between 250-750 nm in 10 mm cuvette with 5 ml/mL concentration.  
X-ray photoelectron spectroscopy (XPS) was carried out on Fe3+-GSH and GSH 
powder at room temperature using a Thermo Scientific 250Xi instrument. 
1.000eV/step was used for a complete scan and 0.050 eV/step used to scan a 
particular element. 
Electrospray ionisation mass spectrometry (ESI-MS, Bruker maXis impact) was 
conducted to further elucidate the complex structure. The complex was dispersed 
in deuterated water and, due to the limited solubility of the Fe3+-GSH complex in 
deuterated water, deuterated water that contained 20 μL HCl. Positive ion polarity 
was used in this measurement with scan from 50 m/z to 1500 m/z.   
The Fe content of the Fe3+-GSH complex was quantified by thermogravimetric 
analysis (TGA), with a measurement taken from 10 °C to 710 °C via a heat 
increase rate of 10 °C/min. The sample was maintained at 710 °C for a further 60 
minutes to ensure the complete decomposition of organic matter.  
4.2.4 Fe3+-GSH complex water stability analysis 
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The stability of the Fe3+-GSH complex in H2O was evaluated by dynamic light 
scattering (DLS) (Malvern, Nano ZS) at 25 °C with a concentration of 0.5 mg·mL-
1 in H2O. Ultrasonic agitation of the solution was conducted prior to analysis. 
Further analysis of the same samples was carried out after 24 hours at room 
temperature without any further sample agitation.  
4.2.5 Fe3+-GSH complex magnetism evaluation 
Fe3+-GSH complex magnetism was measured with from 0-3 T at room 
temperature by Vibrating-sample magnetometer (Quantum Design, SQUID VSM 
system).  
4.2.6 Fe3+-GSH complex stacking structure investigation 
Powder X-ray diffraction (XRD) analysis was scanned from 5°-60° at room 
temperature, results were fitted by the Lorentz system, before the packing mode 
was determined using Bragg’s law and the Scherrer equation.  
𝒏𝝀 = 𝟐𝒅𝒉𝒌𝒍 𝐬𝐢𝐧 𝜽 Bragg’s law 
where n is a positive integer, λ is the wavelength of the incident wave, θ is 






where τ is the mean size of the ordered (crystalline) domains, Κ is Scherrer 
constant, λ is X-ray wavelength, β is FWHM (Full Width at Half Maximum) of XRD 
peak, θ is scattering angle. 
4.2.7 Cytotoxicity tests with Fe3+-GSH complex 
The Fe3+-GSH complex was dispersed in cell culture medium at an initial 
concentration of 2.5 mg·mL-1. L929 murine fibroblasts were cultured (37 °C, 5% 
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CO2) in Dulbecco’s modified Eagle’s medium (DMEM) supplemented with 10 
vol.% Fetal bovine serum (FBS), and 0.5 vol.% penicillin–streptomycin. The cell 
suspension (2×104 cells·mL-1) was transferred to a 96-well-plate (100 µL perwell), 
followed by the addition of increasing Fe3+-GSH concentrations from 0.125 up to 
1.25 mg·mL-1 in each well. The cell viability was quantified by alamarBlueTM assay 
after 1 to 7-day culture. Cells cultured on either TCPs or NTCPs were selected 
as either positive or negative control, respectively. 
4.2.8 Metalloproteinase 13 (MMP 13) regulation study 
10 mg/mL Fe3+-GSH complex was prepared in 120 mM HCl solution and diluted 
by deionised water to 2.308 mg/mL. GSH was dissolved in 120 mM HCl solution 
(1.765 mg/mL, regards TGA data) and set as control group to compare the effect 
with Fe3+-GSH complex. Both complex and GSH solution were further diluted by 
H2O (×4) and each 20 µL diluted samples were added into each well of 96-well- 
plate, followed by 80 µL H2O.  
Pro-MMP 13 was activated following the commercial protocol. Briefly, 5 µL MMP 
13 (10 µg/20 µL) was dissolved in AMPA working solution (1 mM) to 1 µg/mL and 
then incubated at 37 °C for 40 minutes. Activated MMP 13 was diluted by p-
aminophenyl mercuric acetate (AMPA) solution (2 mM) to 25 ng/mL and then 
immediately added to samples in a 100 µL/tube to ensure that the final 
concentration of enzyme was 12.5 ng/mL and the testing samples were 25 µL/mL. 
Deionised water with equal volume of APMA solution (2 mM) was set as a blank 
and deionised water with equal volume of activated MMP 13 was set as the none 
treatment group (control group).  
After 12-hour or 24-hour reactions, retained MMP 13 activity was quantified using 
a MMP activity assay kit (Fluorometric Green, ab112146). Each 50 µL of reacted 
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sample was pipetted into a new 96-well-plate, followed by 50 µL MMP Green 
Substrate solution. MMP 13 activity was recorded in fluorescence after a 1-hour 
reaction in the dark at 37 °C using a microreader (Ex/Em=490/525 nm). 
4.2.9 Statistical analysis 
All the measurements were carried with at least 3 replicates (n≥3). Significant 
difference was calculated through ANOVA with p value of 0.5 and presented as 
*p ≤ 0.5, **p ≤ 0.1, ***p ≤ 0.01, ****p ≤ 0.001, *****p ≤ 0.0001. 
4.3 Results and discussion 
To confirm complex formation upon GSH addition to FeCl3 solution, UV-Vis 
spectroscopy was used to track metal-chelate coordination for various molar 
ratios after 30 minutes, when the solution colour remained consistent. The 
specific absorbance peak at 456 nm was ascribed to Fe-S formation.(196) 
However, following Fe3+-GSH complex formation, two additional absorption 
peaks were detected in this system at positions of 452 nm and 550 nm (Figure 
4.2a) that didn’t present in the spectrum of FeCl3 solution (Figure 4.3). These 
peaks are attributed to Fe3+-GSH coordination.(197) A regular decrease in 
absorbance intensity was observed in solutions containing a decreasing molar 
ratio of FeCl3:GSH (6 → 1), until no peak could be detected in solutions containing 
a molar ratio lower than 1 (Figure 4.2). This observation can be rationalised by 
the fact that when solutions with a FeCl3:GSH molar ratio of 1ː1.2 or lower were 
analysed, Fe2+ was present exclusively and so no Fe3+-associated absorbance 
could be recorded, illustrating that binding between Fe3+ and GSH occurred only 
at increased FeCl3:GSH molar ratios (i.e. >1). This observation also reveals that 
the thiol-induced reduction of Fe3+ to Fe2+ is expected to occur prior to Fe3+ 
chelation in solutions with increased GSH content, and that the chelating 
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interaction detected by UV-Vis spectroscopy was exclusively between GSH and 
Fe3+, rather than between GSH and Fe2+, in solutions with decreased GSH 
content.  
 
Figure 4.2 UV-Vis Spectroscopy of Fe3+-GSH complex solution formed in H2O 
with 40 mM FeCl3. (a): Full wavelength spectrum of solutions containing an 
FeCl3:GSH molar ratio of either 6:1 (black) or 1:1.5 (orange). (b): Tracking 
of 452 nm (right-y-axis) and 550 nm (left-y-axis) absorbances recorded in 
solutions with varied FeCl3:GSH molar ratios from 6:1−1:1.15. 
 
Figure 4.3 UV-Vis spectrum of a 40 mM FeCl3 aqueous solution depicting 
absorption peaks at 452 nm and 550 nm. 
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Monitoring the colour of the Fe3+-GSH complex-yielding solution (FeCl3:GSH= 
1:1) revealed that the starting yellow-like ferric chloride solution immediately 
shifted to a dark green colour for approximately three seconds upon addition of 
GSH (Figure 4.4A). The solution then became lighter yellow, in comparison with 
the starting FeCl3 solution, as shown in Figure 4.4A. The quick formation of dark 
green solution is attributed to the reduction of Fe3+ to Fe2+, and the oxidation of 
the GSH thiol, whereby either a disulfide bridge forms between two GSH 
molecules, a Fe-S bond forms, or a combination of both may form depending on 
the selected Fe3+:GSH molar ratio (Figure 4.4B). As the pH of the solution 
containing both FeCl3 and GSH is acidic (pH < 3), the disulfide bridge may be 
reduced and Fe2+ undergo oxidation after approximately 3 seconds rather than 
air oxidation which usually takes days in sealed environment, when the light 
yellow solution formed. Then ethanol was added into the yellow solution as 
presented in Figure 4.4A, f, yielding a pale red precipitate (Figure 4.4A, g), which 
was washed by ethanol for three times and dried at 37 °C for further 
characterisation. The proposed mechanism for complex formation is provided in 
Figure 4.4B.  
 
Figure 4.4 Colour solution change that accompanies the transition of FeCl3 
solution to the precipitated Fe3+-GSH complex (A) and proposed mechanism 
of Fe3+-GSH complex formation (B). 
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The capability of GSSG to induce iron oxidation, as shown in step 2, was 
confirmed by the GSSG-induced colour change of a FeCl2 solution. The solution 
was shifted from colourless to pale red colour, which is ascribed to the formation 
of a Fe3+ coordinated GSH complex (Figure 4.5). This phenomenon confirmed 
the redox reaction between S-S bond Fe2+ and the possibility of forming a stable 
Fe3+-GSH complex.  
 
Figure 4.5 Colour change of the ferrous chloride solution following addition of 
oxidised glutathione, describing the transition from the Fe2+ oxidation state 
to the Fe3+-GSH complex. 
The iron valence of the Fe3+-GSH complex was evaluated by 57Fe Mössbauer 
spectroscopy at room temperature, 293 K (Figure 4.6). All iron in the complex 
was confirmed to be ferric (Fe3+) valance, with no evidence of any magnetically 
ordered phases.(192) (193) (198) Approximately 60% of the spectral area is 
consistent with Fe3+ with an octahedral structure that is slightly distorted towards 
tetrahedral in character, as evidenced by the relatively low Δ (doublet 1, centre 
shift (δ) = 0.417 mm·s-1, quadrupole splitting (Δ) = 0.650 mm·s-1), and 
approximately 40% of the spectral area is consistent with a more regular 
octahedral Fe3+ structure (doublet 2, δ = 0.447 mm·s-1, Δ = 0.987 mm·s-1). (192) 
(193) (198)  
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Figure 4.6 Fitted Mössbauer spectrum for the Fe3+-GSH complex powder at 
293K. 
The 1H-NMR spectrum was carried out to investigate the coordinating structure 
of the Fe3+-GSH complex as displayed in Figure 4.7, whereby broader peaks can 
be observed compared to the spectrum of GSH. Peak broadening is ascribed to 
the paramagnetism of ferric ions (Fe3+), which affects the magnetic field of the 
instrument and consequently covered related proton splits. However, an obvious 
shift of the CH2-S (position c) protons from 2.87 ppm to 2.89 ppm and 3.19 ppm 
is evident, and is attributed to Fe-S binding, as the strong metal-chelate 
coordination affects the neighbouring carbon environment.(192) This conclusion 
was also further confirmed and is discussed in the later X-ray photoelectron 
spectroscopy.   
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Figure 4.7 1H-NMR spectra of Fe3+-GSH complex (black) and GSH (blue) in D2O. 
FTIR spectroscopy also revealed differences between the spectra of GSH and 
Fe3+-GSH complex. A significant shift in the C=O peak position from 1708 cm-1 
(GSH) to 1737 cm-1 (Fe3+-GSH complex) suggested the coordination between 
Fe3+ and glutathione carbonyl oxygen (C=O) as presented in Figure 4.8. The peak 
at 2522 cm-1 in GSH, corresponding to a thiol vibration (-SH), disappeared from 
the spectrum of the complex, suggesting Fe-S binding. The peaks at 3271 cm-1, 
1636 cm-1, and 1526 cm-1 correspond to the amine groups of GSH.  
Combining the previous unique spectrum from Mössbauer spectroscopy with 1H 
NMR and FTIR spectra, Fe-S and Fe-O two binding sites in this complex have 
been strongly proved. 
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Figure 4.8 IR spectra of GSH (black) and the Fe3+-GSH complex (red). 
The Fe3+-GSH complex was also found to display specific peaks in its CD 
spectrum (Figure 4.9). Compared with uncoordinated GSH in deionised water, 
the Fe3+-GSH complex presented a broad positive peak from 750 to 460 nm and 
a negative peak from 460 to 302 nm, assigned to Fe3+ coordination. In 60 mM 
HCl solution, no obvious structural change was observed for the GSH molecule, 
however, in the spectrum of the Fe3+-GSH complex, an abrupt change was 
recorded, whereby the opposite trend was observed, at 750-422 nm and 422-360 
nm, with respect to when the complex was incubated in H2O. This change may 
be due to the presence of H+,(199) suggesting a partly de-complex process in by 
acid and a reversible pH-induced peptide folding within the Fe3+-GSH complex. 
This interesting phenomenon also provided ideas in the study of peptide 
configuration induction via using metal-chelation method.  
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Figure 4.9 Circular dichroism spectra of GSH (grey solid) and Fe3+-GSH complex 
(blue solid) in deionized water and GSH (grey dash) and Fe3+-GSH complex 
(blue dash) in 60 mM HCl. 
Surface element analysis excluded the formation of S-S bonds and further 
confirmed the chemical composition in coordinated binding energy of the Fe3+-
GSH powder. GSH powder was used as a control. The elements present in the 
Fe3+-GSH complex are presented in Figure 4.10, which reveals that significant 
shifts were detected in C=O, C-O and S-related bonds (Figure 4.11). No S-S bond 
was detected in this complex, which would be revealed by a peak at 166 eV, or 
greater.(200) The thiol group is protected from forming disulfide bridges with other 
GSH molecules by Fe3+ chelation. In addition, no evidence for Fe2+ was found, 
which would be anticipated to appear at 708 ev,(201) rather than the pre-peak, 
which is normally observed in Fe related compounds.(202) This confirmed the 
exclusive existence of ferric iron, consistent with the results from Mössbauer 
spectroscopy. 
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Figure 4.10 X-ray photoelectron spectroscopy (full spectrum of elements) of 
Fe3+-GSH complex and GSH. 
 
Figure 4.11 X-ray photoelectron spectra of the Fe3+-GSH complex and GSH, C1s 
(a), S2p (b), O1s (c). Fe2p (d) and Fe3p (e) of Fe3+-GSH complex. 
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X-ray powder diffraction analysis is a powerful technology for structure analysis. 
The results from this Fe3+-GSH complex powder revealed that 2θ=23.58° with a 
full width at half maximum value of 12.13°, as shown in Figure 4.12a. The d 
spacing of the complex was calculated to be 0.38 nm, and Dp=0.70 nm. The Fe3+-
GSH complex was confirmed to possess a 3-layer packing mode, which varied 
markedly to the crystal structure that was obtained for FeCl3·6H2O (Figure 4.12b), 
confirming that a new stacking structure is formed for the Fe3+-GSH complex. The 
loss of crystal structures also suggested successful synthesis of this new 
complex.  
 
Figure 4.12 X-ray powder diffraction spectrum of Fe3+-GSH complex (a) and 
Iron(III) chloride hexahydrate (FeCl3·6H2O) (b). 
Fluorescence spectroscopy exposed an emission peak at 555 nm under 
excitation wavelength of 408 nm for the Fe3+-GSH complex dispersed in 
deionised water (Figure 4.13a). This peak was also present in the spectrum 
corresponding to a mixture of FeCl3 and GSH (Figure 4.13b). Upon the addition 
of HCl to the complex solution, the emission peak at 555 nm disappeared. A peak 
at 473 nm position formed, which lies between values of pure GSH (470 nm) and 
FeCl3 (493 nm) (Figure 4.13b). The peak at 555 nm is considered to result from 
the strong binding between Fe3+ and GSH, yielding a rigid structure that provides 
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a new emission peak. Its disappearance after adding HCl suggests that this 
structure is not stable in acidic solution, with the coordination between Fe3+ and 
GSH reduced, as supported by the accompanying solution colour change from a 
turbid pale yellow/creamy colour to a transparent colourless solution. 
 
Figure 4.13 Fluorescence spectra analysis of the Fe3+-GSH complex. (a): Fe3+-
GSH complex in deionised water with concentration of 1.0 mg/mL, initial 
status (solid) and after adding 20 µL HCl (dash) under 408 nm excitation 
wavelength. (b): Fluorescence spectrum of FeCl3 (−−), GSH (−−) and FeCl3-
GSH mixture with a molar ratio of 1.2:1 (―), 1:1 (―) and 1:1.2 (―). Spectra 
were recorded with an excitation wavelength of 408 nm. 
Thermogravimetric analysis (TGA) was carried out to further corroborate the 
chemical composition and composition of the complex. As observed in Figure 
4.14, the first mass loss of 12.0% was considered due to water evaporation; the 
next mass loss from 88.0% to 11.5%, which commenced at 148.3 °C, is ascribed 
to the loss of GSH. After heating up to 611.8 °C, the complex max remained 
constant at 11.5%, which was due to the presence of iron. Consequently, it was 
found that the complex contains 87% GSH and 13% Fe by mass. This is very 
close to the theoretical composition of 84.6% GSH and 15.4% Fe, based on a 
total complex mass of 145.4 mg that contains 123 mg GSH. 
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Figure 4.14 TGA thermogram of Fe3+-GSH complex. 
Although Fe was coordinated to water-soluble GSH, the solubility of the Fe3+-
GSH complex in water remained low due to the ionisation equilibrium of Fe itself. 
Iron ions tend to gain hydroxide ligands in neutral and basic water. Mass 
spectroscopy analysis revealed peaks at 615 m/z, attributed to GSSG, and 308 
m/z, attributed to GSH (Figure 4.15). In contrast to mass spectrometry, XPS 
investigations revealed the absence of S-S bridges, suggesting that the formation 
of the oxidised product in the mass spectra is attributed to the electron source 
forming ionised species, which form GSSG in the instrument channel. Significant 
enhancement in peak intensity was observed after adding 20 μl HCl (final 
concentration of HCl was 120 mM), from 8.9×105 to 13.2×105 peak intensity at 
615 m/z and from 0.8×105 to 5.3×105 at 308 m/z. The peak at 669 m/z confirms 
the formation of the GS-Fe-SG complex, although its intensity surprisingly 
increased upon the addition of HCl. The enhancement of this peak following HCl 
addition, together with the change in solution colour from medium yellow to 
almost a colourless solution, suggested the ionisation of the Fe3+-GSH complex 
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had occurred, resulting in the oxidisation of GSH to GSSG, and the partial 
formation of Fe2+ species.  
 
Figure 4.15 Mass spectra of Fe3+-GSH in D2O without (a) and with HCl (b). 
DLS analysis revealed that the Fe3+-GSH complex was stable in water, leading 
to nanoaggregates with an average effective size of 255±4 nm 
(PDI=0.258±0.015). Following 24-hour storage in water at room temperature, the 
complex remained well dispersed with an average effective size of 257±2 nm 
(PDI=0.247±0.008, Figure 4.16). This characteristic may be exploited to generate 
bespoke Fe3+-GSH carriers capable of the prolonged, or redox-mediated, release 
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of GSH to, for example, chronic tissues that have downregulated levels of 
GSH.(169)  
 
Figure 4.16 The effective size of Fe3+-GSH in H2O at a concentration of 0.5 
mg/mL, initial status (solid) and storage in water for 24 hours (dash). 
The magnetic property of Fe3+-GSH was observed using a vibrating-sample 
magnetometer. The increase in magnetic moment from -0.1474 emu/g to 0.1474 
emu/g was recorded as the increasing magnetic field within 3 T, revealing the 
paramagnetism of the complex (Figure 4.17). This paramagnetic property under 
3 T, which is the widely used magnetic field clinically for magnetic resonance 
imaging (MRI), provided potential application of this Fe3+-GSH complex, for 
example, as a potential contrast agent. Combining its stable dispersion in water 
as nanoaggregates (Figure 4.16), great potential can also be expected in 
prolonging its paramagnetism in vivo for a time-dependent observation through 
MRI.   
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Figure 4.17 Vibrating-sample magnetometer measurement of Fe3+-GSH from -3 
T to 3 T magnetic field at room temperature. 
Following systematic characterisation of the complex, attention moved to its 
applicability within a biological environment. Cytotoxicity experiments were 
carried out with L929 mouse fibroblasts and confirmed high cellular tolerability of 
the Fe3+-GSH complex. Growth and proliferation of L929 cells were measured 
during a 7-day culture (Figure 4.18) with all the complex concentrations used in 
the cell culture medium, strongly supporting the excellent complex 
cytocompatibility (Table 4.1). Even compared with TCPs, only temporary 
inhibition was found in cell proliferation in the first 3 days. After 5-day culture, no 
significant difference could be observed in cell growth with cells cultured with 
either 0.125 mg/mL, 0.25 mg/mL, 0.5 mg/mL or 0.75 mg/mL of Fe3+-GSH. After 
7 days culture, L929 cells in 0.125 mg/mL presented significant higher viability 
and no significant difference was found in 0.25 mg/mL and 0.5 mg/mL condition. 
When high Fe3+-GSH content (> 0.5 mg/ml) was supplemented to the cell culture 
medium, cells proved to grow slower with respect to cells cultured on TCPs, 
suggesting a significant GSH-induced impact on cellular activity at increased 
complex concentrations. In addition to possessing cellular tolerability, the Fe3+-
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GSH complex proved also to be stable following 24-hour incubation in cell culture 
medium, suggesting long-lasting GSH storing capability (Figure 4.19, a-d). 
Provided the relaxation time can be evaluated, potential applicability as magnetic 
resonance contrast agent might be additional advantages of this complex.  
 
Figure 4.18 L929 cell viability without/with Fe3+-GSH complex for 7 days culture.  
- 113 - 
 
Figure 4.19 Optical images captured following 1-day (a-d) and 7-day (e-h) culture 
of L929 murine fibroblasts on either TCPs (a, e), or cells culture medium 
supplemented with Fe3+-GSH complex at a concentration of 0.125 mg·mL-1 
(b, f), 0.25 mg·mL-1 (c, g) or 0.5 mg·mL-1 (d,h). Scale bar=100 µm. 
Table 4.1 Statistical analysis of L929 cells viability following 7-day cell culture on 
either TCPs or cell culture medium supplemented with varied concentrations 
of Fe3+-GSH complex. p ≤ 0.5 (*), p ≤ 0.1(**), p ≤ 0.01 (***), p ≤ 0.001 (****).  
 1 day 2 days 3 days 5 days 7 days 
TCPs 
***    
 ***   
  ****  
   **** 
0.125 mg/ml 
****    
 ----   
  ****  
   **** 
0.25 mg/ml 
****    
 ***   
  ****  
   *** 
0.5 mg/ml 
****    
 ***   
  ****  
   **** 
0.75 mg/ml 
****    
 ****   
  ****  
   **** 
1 mg/ml 
****    
 ****   
  ****  
   *** 
1.25 mg/ml 
**    
 ****   
  ****  
   *** 
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MMP 13 activity decreased to 79.5±6.7% after 12-hour incubation with the 
complex (Figure 4.20). A further decrease to 77.6±2.1% was observed over the 
next 12 hours. After 48 hours incubation, MMP 13 activity was downregulated to 
73.9±1.0%. A significant difference was shown at time points, compared with the 
MMP 13 group. Conversely, no significant difference was observed in the GSH 
group. This quick and lasting downregulation proved the ability of the Fe3+-GSH 
complex to inhibit MMP 13 activity, and suggested great potential for the complex 
to be applied to inflammation, wound, and arthritis management by 
downregulating MMP activity. 
 
Figure 4.20 MMP 13 activity following incubation with Fe3+-GSH or GSH for (a) 
12 hours, (b) 24 hours, (c) 48 hours.  
4.4 Conclusion 
The formation of a Fe3+-GSH complex without sulfur within its structure is 
reported and characterised for the first time. Aggregate formation of the complex 
in water yielded stable particulates with an initial average effective size of 255±4 
nm. Such aggregates dispersed in aqueous solution and were found to be non-
cytotoxic against L929 fibroblast cells. Fibroblast growth and proliferation was 
enhanced versus TCPs after seven days of cell culture, suggesting that the 
material has great compatibility to L929 cells and also potential ability in GSH 
storing in cell culture medium. Additionally, the complex kept reducing the activity 
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of MMP-13 over 48 hours, rendering it a highly promising candidate as a 
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Chapter 5  
An injectable, self-healing and MMP-inhibiting hyaluronic 
acid gel formed via crosslinking with an iron-glutathione 
complex 
▪ This chapter has been published. Reference [Gao, Z., Yang, X., Jones, E., 
Bingham, P.A., Scrimshire, A., Thornton, P.D. and Tronci, G. 2020. An 
injectable, self-healing and MMP-inhibiting hyaluronic acid gel via iron 
coordination. International Journal of Biological Macromolecules. 165, 
pp.2022–2029.] 
Regulating the activity of matrix metalloproteinases (MMPs) is a potential strategy 
for osteoarthritis (OA) therapy, although delivering this effect in a spatially and 
temporally localised fashion remains a challenge. Aiming to develop a material-
based approach to restore tissue homeostasis and reduce patient pain, this 
chapter presents an injectable and self-healing hydrogel enabling MMP-13 
regulation and biomechanical competence in situ (Figure 5.1). The hydrogel is 
realised exploiting the prompt coordination between hyaluronic acid (HA) and a 
recently developed cell friendly iron-glutathione complex in aqueous environment. 
Complete solution gelation was successfully achieved within 1 minute at room 
temperature, with the resulting hydrogel displaying up to 300% in shear strain 
and no toxic effects to ATDC 5 chondrocytes, in line with the self-healing property 
and biocompatibility requirements of knee joint interventions. Together with the 
coordination capability with HA, the presence of the iron-glutathione complex was 
key to induce significant inhibition of MMP-13 activity in defined solutions in vitro, 
unlike the case of a commercial HA injection (OSTENIL® PLUS). 24-hour 
incubation with a clinical synovial fluid sample collected from a late-stage OA 
patient revealed reduced MMP activity of 81.0±7.5% in the presence of the 
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reported hydrogel, compared to 92.3±27.3%  when OSTENIL® PLUS was 
included and  100.0±17.6% in native synovial fluid, providing prospective 
improvement in clinical treatment compared to a commercially available 
medication.  
 
Figure 5.1 Illustration of self-healing Fe3+-GSH hydrogel for osteoarthritis 
injection.  
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5.1 Introduction 
OA is a chronic and irreversible disease which results in continuous cartilage 
degradation, increased joint friction, and pain. The onset and progression of OA 
is closely linked to proteolytic imbalances, whereby upregulated activity of MMPs, 
particularly MMP-13 (collagenase), results in the pathological breakdown of 
articular cartilage.(203-205). MMP-13 concentration strongly correlates to VEGF 
concentration, which plays an important role in angiogenesis and can serve as a 
biomarker for OA diagnosis and therapeutic monitoring.(206) In addition, the 
overexpression of MMP-13 is found in advanced osteoarthritic synovial fluid.(207) 
Injectable, non-cytotoxic and biomechanically viable materials that are able to 
inhibit MMP-13 are highly sought to restore tissue homeostasis and minimise the 
risks of knee replacement.(208)  
Injectable materials enable the delivery and localisation of therapeutic 
compounds at a target diseased site. In particular, injectable materials that mimic 
the features of the extracellular matrix (ECM) are ideal therapeutic scaffolds since 
they enable cell attachment, proliferation and temporally controlled mechanical 
function with minimal toxic effect following degradation.(209-210). As such, they 
have been widely employed as carriers for improved mesenchymal stem cell 
(MSC) delivery for bone repair and OA management.(211) Hydrogel systems that 
contain synthetic polymers have shown promise as materials for OA 
management due to their injectability and versatility in presenting bioactive 
functionalities that downregulate MMP activity and prolong the activity of 
encapsulated MSCs.(212) Yet, the limited degradability of many synthetic 
polymers, and the demands of polymer synthesis make their translation to 
commercial products challenging. The design of injectable hydrogels from ECM-
derived polymers that can correct proteolytic imbalances may provide an 
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alternative cell-free and regulatory-friendly strategy for OA management, which 
avoids non-biodegradable synthetic polymers. 
HA is an anionic non-sulfated glycosaminoglycan that constitutes one of the main 
components of cartilaginous ECM.(213) Consequently, commercial HA injections, 
for instance OSTENIL® PLUS, are routinely applied in the clinic for the 
management of osteoarthritic joints, where they provide for mechanical 
supplementation. Significantly improved knee function and pain relief were 
confirmed through the Visual Analog Scale (VAS) score and the Western Ontario 
and McMaster Universities Osteoarthritis Index (WOMAC) score. (138) (214) HA 
injections are usually suggested to be delivered every 1-2 weeks to the joint 
cavity, although they are unable to control OA-related MMP upregulation. Despite 
HA’s capability to interact with, and stimulate chondrocytes in vivo, these 
products are only designed to offer a palliative, short-lived biomechanical solution 
that is used as a last resort prior to joint replacement. Intelligent HA formulations 
that include therapeutics for OA treatment through MMP-13 inhibition, and retain 
mechanical stability, are highly sought. To pursue this vision, a cell-friendly iron-
glutathione (Fe3+-GSH) complex recently reported from previous research in 
Chapter 4.(215) was investigated for use as both a crosslinker of HA to yield an 
injectable hydrogel, and as a potential therapeutic to inhibit MMP-13 activity, 
exploiting the competitive metal-coordinating reaction between complex iron (Fe) 
and free sulfhydryl groups of active MMPs.  
Hydrogel injectability has been pursued via dynamic covalent chemistries in 
thermo-reversible biopolymer-based hydrogels, including Schiff-base 
reactions,(216) Diels-Alder reactions (DA) click coupling,(217-218) as well as via 
thermal gelation mechanisms(219) compliant with injection-mediated delivery. 
On the one hand, the formation of covalently crosslinked hydrogels with 
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appropriate mechanical properties in physiological conditions to reduce joint 
friction has up to now proven challenging. This is largely due to the fact that the 
presence of covalent crosslinks reduces hydrogel’s dynamic tensile, compressive 
and shear strain, limiting hydrogel’s ability to bear multiple load-bearing cycles, 
as in the case of articular cartilage. On the other hand, although thermosensitive 
polymer formulations have been developed, only a limited number have been 
made with HA formulations free of the synthetic polymer phase.(219)  
Other than covalent networks, redox-based self-healable and injectable polymer 
hydrogels were achieved that can withstand relatively high shear strain 
(~50%).(140) (220) Likewise, metal-coordinated hybrid materials have been 
reported serving as electroconductive materials,(221) catalyst supports,(222) and 
for magnetic resonance imaging(186) (223). Ultimately, composite hydrogels 
have been made of multiple biopolymers and bioglass and ionically crosslinked 
by calcium dications.(224) The composite material is able to withhold quercetin, 
an MMP inhibitor, so that 70% reduction in MMP-13 expression was reported 
after 48 hours, which proved key to induce cartilage repair after 12 weeks in vivo. 
These studies provide novel design concepts that harness the functionalities of 
metals and peptides, aiming to build simple ECM mimetics with flexible 
mechanical properties and MMP inhibition capability. 
In this chapter, the straightforward creation of a non-toxic HA-based hydrogel that 
is injectable and self-healing is reported. HA combined with an iron (III)-
glutathione (Fe3+-GSH) complex results in the formation of a physical hydrogel 
upon co-injection. Crucially, the Fe3+-GSH complex has the dual function of being 
the crosslinker within the hydrogel, and also providing a therapeutic effect for 
inhibiting MMP activity, as confirmed with synovial fluid (SF) clinical samples 
collected from patients with late-stage OA. Consequently, the hydrogel may act 
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as a self-healable scaffold that reduces joint friction and halts cartilage 
degradation, whilst boosting local cell function. Delivery of this system in situ has 
significant potential in OA therapy, aiming to prevent the degradation of cartilage 
whilst correcting growth factor concentrations and cellular activity towards 
cartilage repair.  
5.2 Materials and methods  
5.2.1 Materials  
The hyaluronic acid sodium salt (molecular weight: 1,200 kDa, cosmetic grade) 
was purchased from Hollyberry Cosmetic. GSH was purchased Alfa Aesar. 
alamarBlueTM assay kit was from ThermoFisher Scientific. Human recombinant 
Pro-MMP 13 was purchased from Antibodies.com, and the MMP activity assay 
kit (Fluorometric Green, ab112146) was from ABChem. All the other reagents 
were provided by Sigma-Aldrich. 
5.2.2 Rheology of HA solutions supplemented with Fe3+-GSH 
Different concentrations of Fe3+-GSH complex were added to the HA solution 
(Table 5.1) to achieve the optimal hydrogel with most stable rheological property. 
To exclude the influence of HA concentration on gel formation, the final 
concentration of HA in the gel-forming mixture was controlled to 1.33 wt.% by 
addition of deionised water. All test group samples were named as “Fe xxx”, in 
which “xxx” corresponds to the volume of Fe3+-GSH solution (µL) in the HA 
solution (mL). All control samples were named as “Ctrl xxx”, in which “xxx” 
corresponds to the volume (µL) of Fe3+-GSH solvent (120 mM HCl) per mL of HA 
solution. 
Fe3+-GSH-supplemented HA solution was injected onto an MCR 302 Rheometer 
(Anton Paar) and pressed by a 25 mm parallel plate (1.5 mm gap) at 37 °C with 
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a variable shear rate to study the viscosity of hydrogels formed with different Fe3+-
GSH complex content.  
Table 5.1 Formulation of different samples. 
Sample name 
HA 
(2 wt.%, mL) 
Fe3+-GSH 
(10 mg/ml, μL) 
HCl 
(120 mM, μL) 
H2O 
(μL) 
Fe 100 1 100 0 400 
Fe 200 1 200 0 300 
Fe 300 1 300 0 200 
Fe 400 1 400 0 100 
Fe 500 1 500 0 0 
Ctrl 0 1 0 0 500 
Ctrl 100 1 0 100 400 
Ctrl 200 1 0 200 300 
Ctrl 300 1 0 300 200 
Ctrl 400 1 0 400 100 
Ctrl 500 1 0 500 0 
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5.2.3 Preparation of Fe3+-GSH-HA hydrogel (Fe 300) 
The Fe3+-GSH complex was prepared using previous method.(215) Briefly, 123 
mg (0.4 millimoles) of GSH was added to 4 mL FeCl3 aqueous solution (0.1 M), 
and the mixture was mildly agitated by vortex mixing for 2 min until the solution 
became yellow. Then, the complex was precipitated by adding 40 mL ethanol 
(×3) and collected by centrifugation at 10,000 rpm for 15 min. The Fe3+-GSH 
complex was dried at 37 °C for further use.  
10 mg of Fe3+-GSH complex was dissolved in 1 mL HCl solution (120 mM). Each 
300 μL Fe3+-GSH complex solution was added to 1 mL hyaluronic acid solution 
(2 wt.%) and stirred at room temperature for 1 min to obtain a self-healing 
hydrogel (Fe3+-GSH gel).  
The self-healing behaviour of all hydrogels formed was characterised by 
determining the reversible viscosity from a low shear strain (0.01%) for 200 s, 
followed by a high shear strain (500%) measurement for 100 s at 37 °C. Ten low-
to-high shear strain gaps were measured in this process using an Anton Paar 
MCR 302 rheometer.  
5.2.4 Determination of hydrogel rheological properties 
The shear modulus (G’ and G’’) of the Fe3+-GSH crosslinked hydrogel (Fe 300) 
was measured via a frequency sweep using an MCR 302 rheometer (Anton 
Paar). This method was set with a 25 mm parallel plate at 37 °C, 1.5 mm gap, 
from 1-100 rad·s-1 under 5% amplitude. G’ and G’’ were determined at 37 °C over 
a shear strain range of 0-500% with a constant angular frequency (5 rad·s-1). 
Every 1.0 mL volume of Fe3+-GSH gel was injected onto the sample plate and 
slightly pressed by a 25 mm parallel plate geometry with a gap of 1.5 mm. 
Hyaluronic acid with the same amount of HCl solution only was measured as a 
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control for both shear modulus and shear strain. All the experiments were 
repeated at least three times. 
5.2.5 Molecular mechanism study  
57Fe Mössbauer spectroscopy was applied to study iron chelation and valence in 
self-healing hydrogel. Measurements were carried out using acrylic absorber 
discs (area: 1.8 cm2) loaded with a dried gel sample to achieve a Mössbauer 
thickness of 1. The 14.4 keV γ-rays were supplied by the cascade decay of 25 
mCi 57Co in Rh matrix source, oscillated at constant acceleration by a SeeCo 
W304 drive unit, detected using a SeeCo 45431 Kr proportional counter operating 
with 1.745 kV bias voltage applied to the cathode. All measurements were carried 
out at 293 K over a velocity range of ±6 mm·s−1, and were calibrated relative to 
α-Fe foil. Spectral data were fitted using the Recoil software package, using a 
single Lorentzian line shape. 
5.2.6 Cytotoxicity studies 
ATDC 5 chondrocytes were cultured (37 °C, 5% CO2) in a mixed medium of 
Dulbecco’s modified Eagle’s medium (DMEM) and Ham’s F12 medium (1:1 in 
volume), supplemented with 5 vol.% fetal bovine serum (FBS), and 1 vol.% 
penicillin-streptomycin. A defined amount of self-healing gel was transferred into 
individual wells of a 96-well-plate and diluted by cell culture medium to a final 
concentration of 0 µL (TCPs), 5 µL, 10 µL, 20 µL, 30 µL, 40 µL and 50 µL per 
well, followed by addition of 100 µL cell suspension (5×104 cells/mL) in each well 
(n=4). The ATDC 5 cell metabolic viability was quantified by alamarBlueTM assay 
after 1-day and 5-day culture. Cells cultured on TCPs were set as the control 
group.  
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5.2.7 Acellular MMP-13 inhibition study 
The self-healing gel, as well as an HA solution and a commercial HA gel for OA 
injection, OSTENIL® PLUS (both with the same HA concentration as the self-
healing gel), were added to deionised water (×4). Then, 20 µL of each sample 
was added to individual wells of a 96-well plate, followed by adding 80 µL H2O 
per well.  
Pro-MMP 13 was activated following the manufacturer protocol. Briefly, 5 µL 
MMP-13 (10 µg MMP-13/20 µL sample) was dissolved in a AMPA working 
solution (1 mM) to 1 µg/mL and then incubated at 37 °C for 40 min. Activated 
MMP-13 was diluted with AMPA solution (2 mM) to 25 ng/mL and then 
immediately added into the sample wells (each containing 100 µL of the sample), 
corresponding to a final MMP-13 concentration of 12.5 ng/mL to cover the 
enzymatic concentration (6 ng/mL) recorded in synovial fluid samples of 
advanced OA patients.(207) Deionised water with an equal volume of APMA 
solution (2 mM) was set as the blank, and deionised water with an equal volume 
of activated MMP-13 was set as the none treatment group.  
After 12-hour or 24-hour incubation, MMP-13 activity was quantified via 
fluorometric assay (Fluorometric Green, ab112146, Abcam).(225) 50 µL of each 
sample was pipetted into a new 96-well-plate, followed by 50 µL of MMP Green 
Substrate working solution. MMP 13-activity was recorded in fluorescence after 
1-hour reaction in the dark at 37 °C using a microplate reader (Thermo Scientific 
Varioskan® Flash, Ex/Em=490/525 nm).  
5.2.8 MMPs regulation study with patient collected synovial fluid 
Synovial fluid (SF) samples were collected from late-stage osteoarthritic patients 
at Chapel Allerton Hospital (Leeds, UK) under ethical approval granted by the 
- 126 - 
National Research Ethics Committee (ethical approval number: 07/Q1205/27). 
SF samples were stored at -80 ˚C until use. 
A fluorometric assay kit (Fluorometric Green, ab112146) was used to measure 
the total proteolytic activity in both SF and hydrogel-incubated SF samples. SF 
samples were diluted with the MMP assay buffer (×4), and the final Fe3+-GSH 
crosslinked gel dose was increased (×4). 50 µL of diluted SF were mixed with 40 
µL of Fe3+-GSH crosslinked gel, and 10 µL of deionised water was supplemented 
in each well to achieve a final concentration of 100 µL/mL [Fe3+-GSH crosslinked 
gel/solution]. The fluorometric assay was conducted after 24-hour incubation 
following the same assay protocol reported for MMP-13 activity measurement.  
5.2.9 Statistical analysis  
All the samples were tested with at least 3 replicates (n≥3) and presented as 
Mean±SD. Statistical significance level was calculated through one-way ANOVA 
with a p value at 0.05. Final statistical results were presented as *p ≤ 0.05, **p ≤ 
0.01, ***p ≤ 0.001, ****p ≤ 0.0001.  
5.3 Results and discussion  
Attempts to create hydrogels from HA (2 wt.%) and varying amounts of the Fe3+-
GSH complex (10 mg/mL) were conducted, and the optimal hydrogel was formed 
from 300 μL Fe3+-GSH complex (10 mg/mL) and 1 mL HA solution (2 wt.%). A 
significant decrease in viscosity was observed with increasing shear rate from 
0.01 Hz (14,400 Pa·s) to 4 Hz (37 Pa·s), whereas the viscosity remained constant 
at shear rates between 4 Hz and 100 Hz (Figure 5.2a). Compared with the other 
materials created, the high viscosity at low shear rate from 0.01 Hz to 4 Hz proved 
its stability as self-healing hydrogel and suggested a balanced coordination at a 
Fe3+-GSH crosslinker concentration of 300 µL per mL of HA solution.  
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Figure 5.2 Shear rate-Viscosity flow curve of aqueous solutions supplemented 
with varied Fe3+-GSH complex/HA ratio (a), varied concentration of HA 
(control group) (b). The highest viscosity to 14,400 Pa·s was recorded in Fe 
300 sample at 0.01 Hz, indicated by a solid blue line (a).  
On the other hand, in the HA solution control groups, replacement of the Fe3+-
GSH complex with the HCl solution resulted in significantly lower viscosity, 
whereby no significant viscosity variation was observed across the control groups 
(Figure 5.2b). This remarkable difference from Fe 300 proved a successful 
formation of HA gel via Fe3+ metal binding. Consequently, this hydrogel (Fe 300) 
was chosen for further investigation. 
The clear presence of a doublet attributable to paramagnetic Fe3+ can be 
observed, despite the low signal/noise ratio due to the low abundance of Fe3+-
GSH content in the gel. The iron oxidation state in the optimal hydrogel (Fe 300) 
was ferric (Fe3+) occupying octahedral coordination,(198) (226) as determined by 
57Fe Mössbauer spectroscopy, which also confirmed the chelation of Fe3+ to HA 
(Figure 5.3). Furthermore, this only one doublet from Mössbauer spectrum 
suggested a uniform binding of Fe3+-GSH complex to HA, which gave possibility 
that the proposed Fe-S binding in initial complex (Chapter 4) was released when 
it was dissolved in HCl, but the stronger Fe-O binding was remained. And 
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additional Fe-O might form with HA molecules, replacing initial Fe-S sites in the 
complex.  
 
Figure 5.3 Fitted 57Fe Mössbauer spectrum of dry Fe3+-GSH gel network at 293 
K, relative to thin α-Fe foil. Fitted centre shift (δ) = 0.41 ± 0.02 mm·s-1 and 
quadrupole splitting (Δ) = 0.72 ± 0.02 mm·s-1 with HWHM linewidth = 0.21 ± 
0.02 mm·s-1.  
A much higher G’ value (120 Pa) was recorded for the Fe 300 gel that contained 
the Fe3+-GSH crosslinker, compared to the HCl-HA control (10 Pa), again 
indicating that Fe3+-coordination to HA enables gel formation. Constant storage 
moduli (G’= 120 Pa) and loss  moduli (G’’= 70 Pa) of the self-healing gel were 
successfully measured in frequency sweep mode, confirming a predominantly 
elastic behaviour in the range of 1-40 rad·s-1, whilst the material elasticity was 
found to decrease at the increased angular frequency (Figure 5.4a). Although the 
storage moduli is reduced compared to the chemically crosslinked HA hydrogel, 
which was prepared in Chapter 2 and holding a G’ value around 300 Pa (Figure 
2.7), the elastic range was much greater than the chemically crosslinked hydrogel 
(1-10 rad·s-1).This behaviour illustrates the homogeneous nature of the gel. 
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Conversely, the HCl-HA control sample presented an obvious decrease in moduli 
from high to low frequency (Figure 5.4b), which was expected as a nature of 
uncrosslinked polymer solution.  
 
Figure 5.4 Shear modulus of Fe3+-GSH hydrogel (a) and ctrl 300 samples (b) 
recorded during the frequency sweep. 
Figure 5.5a reveals the dependency of dynamic shear modulus under shear 
strain (0.01-500%) for the Fe3+-GSH crosslinked gel. A predominantly elastic gel 
response was observed up to 300% shear strain, whereby both the storage and 
loss moduli remained constant when up to 80% shear strain was applied with 5 
rad/s (0.8 Hz) frequency. These results demonstrate mechanical compliance of 
the hydrogel with the ranges of shear strain (up to 1%) and frequency (0.5-2.0 
Hz) observed in vivo in both connective and fatty tissues.(227) In line with 
previous results, the storage modulus of the Fe3+-GSH coordinated gel (105 Pa) 
was found to be greater than that of the hyaluronic acid control (70 Pa, Figure 
5.5b), demonstrating increased mechanical competence and also the formation 
of hydrogel material, rather than viscous polymer solution.  
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Figure 5.5 Shear modulus of Fe3+-GSH gel (a), HCl control group (b), measured 
via strain sweep. 
During this dynamic viscosity measurement from low shear strain (0.01%) to high 
strain (500%), Fe3+-GSH crosslinked gels presented a stable reversible complex 
viscosity in the range of 37-42 Pa·s and 12-16 Pa·s, respectively (Figure 5.6 
blue). After 10 cycling tests, the reversible property remained without obvious 
fatigued phenomenon, confirming this Fe3+-GSH crosslinked gels to be self-
healing materials.  
The profound degradability of Fe3+-GSH crosslinked hydrogel in aqueous solution 
was confirmed by the decreased viscosity to 0.1-10 Pa·s after being incubated at 
37 °C for 5 days (Figure 5.6 grey). This self-degradable property provided this gel 
promising biomedical potential as injection in avoiding in vivo inflammation. 
Although the mechanism of degradation was not fully studied, both hydrolysis of 
HA chains and Fe3+-decomplexation could affect the degradation 
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Figure 5.6 Dynamic time-dependent viscosity measurement of initial (blue) and 
Fe3+-GSH gel after 5-day self-degradation (grey) at 37 °C. Measurements 
were started with low shear strain (0.01%) for 200 s, followed by another 
100 s at high shear strain (500%) at 37 °C. 
The formation from HA solution to Fe3+-GSH crosslinked self-healing hydrogel 
was presented in (a) and (b) of Figure 5.7. Figure 5.7c reveals the elongation and 
injectability of this self-healing hydrogel, the material can be absorbed (step 1) by 
a syringe and then be injected through the syringe tip (step 2), before undergoing 
extensive elongation (step 3). The sticky property of this self-healing hydrogel 
could also be observed in step 3; in line with previous viscosity analysis, the 
adhesive properties of HA were enhanced by Fe3+-GSH induction. This feature is 
key to enable confined application and adhesion of the gel to cartilage, aiming to 
stabilise the joint cavity and to reduce bone-to-bone friction, which is essential to 
preserve the cartilage interface.(228) 
- 132 - 
 
Figure 5.7 Illustration of Fe3+-GSH hydrogel formation. (a): Molecular 
configuration and physical appearance of the HA solution; (b): Proposed 
coordination structure within, and physical appearance of, the Fe3+-GSH 
hydrogel. (c): Macroscopic properties of Fe3+-GSH gel, being loaded up 
(step 1), injected (step 2) and stretched (step 3). 
The dose of Fe3+-GSH crosslinked HA gel that is non-cytotoxic to ATDC 5 
chondrocytes was then determined via an in vitro cell viability assay (Figure 5.8). 
As expected, the hydrogel reveals a dose dependent cytotoxicity.  At day 1, the 
lower dose (e.g. 5 and 10 µL) of Fe3+-GSH crosslinked HA gel did not show 
significant cytotoxicity compared with that of the TCPs control group (p > 0.05). 
However, the high dose groups (e.g. > 20 µL) significantly reduced the viability of 
ATCD-5 cells compared to the control group (p ≤ 0.01, 0.001, 0.001, 0.05 
respectively). At day 5, only the 5 µL group was not cytotoxic (p > 0.05) but all 
the other higher dose groups were significantly cytotoxic to the cells compared 
with that of the control group (p ≤ 0.05, 0.001, 0.0001, respectively).  Clearly, no 
significant difference in cell viability was observed following 1-day cell culture in 
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either TCPs or lower doses of Fe3+-GSH crosslinked hydrogel (with both 5 µL and 
10 µL dose).  
 
Figure 5.8 ATDC 5 cells viability when growing with Fe3+-GSH gel after 1 day (a) 
and 5 days (b). Data was presented as Mean±SD, statistical analysis was 
carried out between each two groups and labelled as *p≤ 0.05, **p≤ 0.01, 
***p≤ 0.001, ****p≤0.0001, otherwise means no significant difference at 
p=0.05 level. 
Furthermore, the increase in metabolic activity recorded from day 1 to day 5 in 
ATDC 5 cells cultured with 5 30 µL hydrogel (Table 5.2) was similar to that 
measured in cells treated with the TCPs control group (7.9 times). This 
observation indicates that decreased doses (e.g. ≤ 30 µL) of Fe3+-GSH hydrogel 
did not affect the cell proliferation (e.g, cell doubling) in this time window, in 
contrast to the case where higher doses (e.g. ≥ 40 µL) were applied. Given that 
the initial cell seeding density (5,000 cells per well) was maintained across all 
hydrogel groups (5-50 µl), the reduced cellular metabolic activity observed with 
increased gel volume (> 30 µl) is likely attributed to the relatively small number of 
cells cultured with increased sample dosages. This observation may suggest that 
the  gels under 30 µL dose were temporarily toxic after 1-day, however, the 
proliferation of the remaining ATDC 5 cells was not affected, an explanation which 
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is supported by the optical microscope images of cells cultured for 1 (Figure 5.9) 
and 5 days (Figure 5.10). In contrast, no proliferation was observed in both 40 
and 50 µL groups over 5 days. 
Combining toxicity data with initial cell seeding density (5,000 cell/well) enables 
a correlation between cytotoxicity and gel volume  to be made;  5,000 cells are 
tolerant to a maximum gel volume of 0-30 µL. 
Table 5.2 ATDC 5 cell viability increase from 1 day to 5 days in selected sample 
groups. 
Sample ID 
Average cell viability increase  
(Times) 
0 µL (TCPs) 7.9 
5 µL 10.5 
10 µL 7.0 
20 µL 8.8 
30 µL 7.4 
40 µL 0.1 
50 µL 0 
 
 
Figure 5.9 Optical images of ATDC 5 cells after 1-day culture with Fe3+-GSH gel, 
(a) 0 µL (TCPs), (b) 5 µL, (c)10 µL, (d) 20 µL, (e) 30 µL, (f) 40 µL and (g) 50 
µL per well. Scale bar, 100 µm. 
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Figure 5.10 Optical images of ATDC 5 cells after 5-day culture with Fe3+-GSH 
gel, (a) 0 µL (TCPs), (b) 5 µL, (c)10 µL, (d) 20 µL, (e) 30 µL, (f) 40 µL and 
(g) 50 µL per well. Scale bar, 100 µm. 
The capability of the Fe3+-GSH crosslinked hydrogels to inhibit proteolytic activity 
was then assessed, whereby MMP-13 was selected as a well-known upregulated 
protease in late-stage OA. By selecting MMP-13-supplemented aqueous 
solutions as a defined in vitro environment, incubation of Fe3+-GSH hydrogel 
resulted in a reduction of MMP-13 activity after 12 hours (95.7±3.4%). A 
significant reduction in MMP-13 activity (92.9±1.4%) was recorded after 24 hours, 
compared to the positive control group (p<0.001) (Figure 5.11). On the other 
hand, no significant activity difference was observed between MMP-13-
supplemented solutions and the same solutions following incubation with either 
soluble, complex-free GSH (103.1±7.6%) (215) or native HA at both time points 
(98.5±5.0%). In OSTENIL® PLUS, no reduction in MMP-13 activity was seen after 
12 hours, but a significant reduction (p<0.05) in activity was observed after 24 
hours (96.1±1.7%), with respect to the pristine MMP-13 solution. A comparison 
between the Fe3+-GSH crosslinked gel and OSTENIL® PLUS reveals that 
increased MMP-13 inhibition occurred in the presence of the Fe3+-GSH 
crosslinked hydrogel after 12 hours (p<0.01), which was maintained after 24 
hours (p<0.05). These results provide indirect evidence that the hydrogel-induced 
- 136 - 
MMP-13 inhibition was achieved via chelation of respective iron sites with free 
sulfhydryl groups of active MMPs, rather than by complexation of the free zinc 
sites of active MMPs (225) with either the hydrogel’s or GSH’s sulfhydryl groups, 
on the one hand, or HA’s carboxylic groups on the other hand. These 
observations support the key role played by the Fe3+-GSH complex in both 
hydrogel crosslinking and MMP inhibition. 
 
Figure 5.11 Variation of MMP-13 activity in MMP-13–supplemented solutions 
after 12-hour (a) and 24-hour (b) incubation with either the Fe3+-GSH 
crosslinked hydrogel, an HA solution or the OSTENIL® PLUS commercial 
injection. Data was presented as Mean ± SD, statistical analysis was carried 
out between each two groups and labelled as *p≤ 0.05, **p≤ 0.01, ***p≤ 
0.001, otherwise means no significant difference at p=0.05 level. 
A sample of synovial fluid (S162) collected from patients with late-stage OA was 
used to investigate the MMP-regulating capability of the Fe3+-GSH crosslinked 
gel in near-physiologic conditions, and to further corroborate the previous findings 
obtained for hydrogel-mediated MMP-13 inhibition in a defined in vitro 
environment. As the overall proteolytic activity was measured since various 
MMPs, including MMP-1, -2, -3, -7, -8, -9 and -13, were confirmed to have 
significantly increased activity in advanced OA.(203) Figure 5.12 reveals that 
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lower overall MMP activity and, smaller standard deviations, were observed for 
the Fe3+-GSH crosslinked gel (81.0±7.5%) compared to the native SF group 
(100.0±17.6%), with a p-value of 0.0942. Although OSTENIL® PLUS presented a 
lower average value of activity reduction (92.3±27.3%) compared to native SF 
(p=0.6528), a larger standard deviation was recorded for this group versus both 
SF and the Fe3+-GSH crosslinked gel. The results obtained with the clinical SF 
sample, therefore, confirm the competitive MMP inhibition functionality of the 
Fe3+-GSH crosslinked hydrogel with respect to the OSTENIL® PLUS commercial 
control. 
 
Figure 5.12 Variation of MMP activity recorded in a patient collected SF sample 
after 24-hour incubation with either the Fe3+-GSH crosslinked hydrogel or 
the OSTENIL® PLUS commercial injection (n=4). The SF sample was 
collected from a patient (donor S162) with late-stage OA. 
5.4 Conclusion   
A Fe3+-GSH crosslinked injectable hydrogel was prepared in this chapter that 
possessed self-healing and MMP inhibition functionalities. The coordination 
mechanism to yield the hydrogel was confirmed by shear frequency sweep tests, 
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which revealed a storage modulus more than ten times higher than the loss 
modulus. 57Fe Mössbauer spectroscopy revealed that Fe was present in the 
hydrogel as octahedrally-coordinated Fe3+. The hydrogel could hold up to 300% 
shear strain and presented a stable complex viscosity (37-42 → 12-16 Pa·s) after 
10 cycling tests from low to high strain. In vitro, the gel proved to be well tolerated 
by ATDC 5 chondrocytes and able to support cell proliferation during a five day-
culture. Furthermore, the gel demonstrated the inhibition of MMP activity after 24 
hour-incubation in both an MMP-13–supplemented aqueous solution and a 
patient collected sample of synovial fluid, in light of the metal-coordinating 
reaction between thiol-complexed iron(III) and free sulfhydryl groups of active 
MMPs is exploited to induce MMP inhibition. These results therefore demonstrate 
that the hydrogel’s biomechanical competence was successfully integrated with 
drug-free MMP regulation capability. The simple material design, together with 
the hydrogel’s injectability and biochemical and self-healing functionalities 
support further development of this system for drug-free OA therapies.
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Chapter 6  
Summary and Future work 
This project explored the influence of different crosslinking methods in the 
creation of hyaluronic acid-based hydrogels, aiming to create materials for the 
diagnosis or treatment of various diseases. Stiff, elastic, and self-healing 
hydrogels were reported dependent on the method of crosslinking used, which 
have potential to be applied to meet to a range of applications, and to act as 
scaffolds for the creation of a variety of new tissue types.  .  
Chapter 2 developed a chemical hydrogel that contained disulfide bonds (S-S) 
within the covalent crosslinks. Such a material is glutathione-responsive due to 
the dynamic redox reaction between S-S and -SH, which enabled a clear change 
material dimensions to be visualised when the material was incubated in 
simulated wound fluid with variable GSH concentrations. Consequently, this 
novel material may be used for clinical diagnosis to manage wounds by tracing 
the change of GSH levels.  
In Chapter 3,  progress in the application of acellular  biomineralisation was made 
based on the previous cystamine crosslinked HA hydrogel reported in Chapter 2. 
Hydrogen phosphate interaction with crosslinked HA hydrogels was investigated, 
with the presence of hydrogen bonds forming secondary crosslinking network 
confirmed via DFT calculations and FTIR analysis. Hydroxyapatite crystal growth 
was realised in the entire HPO42- and cystamine dual crosslinked HA hydrogel 
network. Mild and facile conditions may provide the possibility for in vivo 
mineralisation since the non-cytotoxic HPO42- treatment was proved, particularly 
for prolonged gradient  bone tissue regeneration.  
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Chapters 2 and 3 focused on chemical crosslinking methods to realise stable and 
stimuli-responsive hydrogels. The dynamic response to thiol-related molecules 
and obvious hydrogen phosphate interaction in cystamine crosslinked hydrogels 
in Chapters 2 and 3 revealed interesting phenomenon of HA-based materials that 
a cystamine crosslinked HA hydrogel can be designed and optimised via HPO42- 
interaction with potential extended diseases applications, from chronic wound 
management to bone therapy.  
Particularly, to further understand the interaction between HPO42- groups and 
cystamine crosslinked HA molecules, systematic computational work in both 
interaction energy calculation and molecular dynamic simulation involving more 
factors such as the length of HA chain, pH influence, solvent and temperature 
effect, could help develop the mechanistic study.   
The successful observation of gradient mineralisation in Chapter 3 achieved 
acellular controllable hydroxyapatite growing within a cystamine crosslinked 
hyaluronic acid network, which made it possible to realise controllable bone 
regeneration in vivo. However, it is unclear whether the existence of biomolecules 
such as amino acids and proteins could affect the process of biomineralisation in 
vivo. As clinical application is the final goal of this project, a study into the stability 
and reproducibility of the hydrogels in a physiologically-relevant environment 
must be determined as the next step. For example, adding the biomolecules 
stated above at appropriate concentrations to the c-SBF solution in which 
mineralisation happened. The metabolism of cells and response to bioactive 
substances, such as alkaline phosphatase, will be particularly important to 
determining hydrogel stability. Providing that biomineralisation  occurs as 
expected under such conditions, a systematic combining of biological 
experiments and mechanical studies on mineralised hydrogels should be carried 
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out, including the proliferation, migration and differentiation of osteogenic cells, 
alkaline phosphatase expression during the mineralisation process and how bone 
density alters during this process. 
Chapters 4 and 5 focused on physical crosslinking methods to achieve a flexible 
and self-healing network for joint tissue treatment, particularly cartilage injection 
for osteoarthritis therapy. As MMPs are highly expressed in OA diseases, a 
material that can facilitate a reduction in the activity of MMPs in OA was sought. 
In Chapter 4, a novel Iron(III)-glutathione (Fe3+-GSH) complex was designed and 
reported, which was also the first time that such a complex being fabricated 
successfully in a straightforward manner while retaining an oxidative valence of 
Fe3+. This Fe3+-GSH complex revealed promising biomedical value, including 
significantly enhanced cell proliferation after 7 days and significant MMP-13 
activity reduction in vitro after 24 hours and 48 hours in accordance with statistical 
analysis. The confirmed water-stable properties from initial 255±4 nm to 257±2 
nm after 24 hours also suggested potential for in vivo use. The single crystal 
structure should be an important point to look at as future work for a better 
understanding in both chelation chemistry and MMP inhibition.  
In Chapter 5, the Fe3+-GSH complex that was fabricated in chapter 4 was applied 
as a novel crosslinker to yield physical and stretchable hydrogel network formed 
due to Fe3+ coordination to the carboxyl groups of HA. The biosafe dosage of the 
hydrogel was found by 5-day cell experiments that 5,000 ATDC 5 cells are 
tolerant to 0-30 µL gel. A statistically significant reduction in MMP-13 activity was 
observed under the biosafe dosage in hydrogel test group compared to both the 
MMP-13 control group in the absence of any additive, and the commercially 
available product OSTENIL® PLUS. When the gel was applied to clinical synovial 
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fluid sample collected from late-stage OA patient a reduced trend in MMP-13 
activity was observed after 24 hours.  
As the data obtained from clinical patient SF samples presented promising results, 
particularly in comparison with a  commercial HA injection, further MMP inhibition 
tests with more clinical samples should be carried out for better statistical analysis. 
Furthermore, MMP expression by native cells in SF extracted from late-stage OA 
patients should be evaluated for a deeper understanding of the hydrogel inhibiting 
function on MMPs. Finally, animal tests in osteoarthritis models should be set up 
to study the function of the hydrogels in inflammation inhibition and cartilage 
repair. For example, inject this hydrogel into decayed cartilages of selected 
animals, the cartilage regeneration can be observed through µCT and histological 
staining. In the meantime, relative MMPs expression levels around treated 
tissues can be traced and recorded  via Real-time Polymerase Chain Reaction 
(RT-PCR) during this experiment.  
Although this project aimed to develop and succeeded in reporting a range of HA-
based hydrogels, there remains  a great deal of work worthy of further 
investigation. For example, it would be highly useful if chemical and physical 
crosslinked hydrogels could be combined to create a dual or multilayer material 
to realise bone repair and reduce inflammation simultaneously. 
With biotechnology development, many difficulties have been conquered one by 
one. The advent of 3D printing technology may enable heart, lung, bone and 
many other organs to be created are no more problems for tissue replacement. 
However, in the meantime the development of dynamic naturally occurring 
substances to help regenerate tissue natively remains extremely valuable. 
Nowadays, 3D printing of natural biopolymer-based hydrogels is revealing its 
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potential in tissue engineering, which could also be something worth investigation 
as future work.  
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Appendix B  
Related publications during PhD projects 
A.1 From Chapter 2 
Gao, Z., Golland, B., Tronci, G. and Thornton, P.D. 2019. A redox-responsive 
hyaluronic acid-based hydrogel for chronic wound management. Journal of 
Materials Chemistry B. 7(47), pp.7494–7501. 
A.2 From Chapter 3 
Gao, Z., Hassouneh, L., Yang, X., Pang J., Thornton, P.D. and Tronci, G. 2020. 
Hydrogen phosphate-mediated acellular biomineralisation within a dual 
crosslinked hyaluronic acid hydrogel. European Polymer Journal. (Accepted) 
A.3 From Chapter 4 
Gao, Z., Carames-mendez, P., Xia, D., Pask, C.M., Mcgowan, P.C., Bingham, 
P.A., Scrimshire, A., Tronci, G. and Thornton, P.D. 2020. The facile and additive-
free synthesis of a cell-friendly iron(III)–glutathione complex. Dalton 
Transactions. 49. pp. 10574-10579.  
A.4 From Chapter 5 
Gao, Z., Yang, X., Jones, E., Bingham, P.A., Scrimshire, A., Thornton, P.D. and 
Tronci, G. 2020. An injectable, self-healing and MMP-inhibiting hyaluronic acid 
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Index 
Information of calibration curves used in this project: 
(1) TNBS calibration equation of cystamine:  
y=0.0666x-0.0184, R2=0.9933, y=absorbance, x= cystamine concentration, mM. 
(2) TNBS calibration equation of ethylenediamine: y=0.0658x-0.0246, 
R2=0.9743, y=absorbance, x=ethylenediamine concentration (mM). 
(3) RITC-dextran calibration equation:  
y=0.0011x-0.004, R2=0.9995, y=absorbance, x= RITC-dextran concentration 
(µg·ml-1)  
